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Abstract 
 
Introduction: Primary Care Psychologists make use of psychiatric classifications for the 
assessment of patients in general practice. However, customary psychiatric diagnoses, such as 
the DSM category of somatic symptoms and related disorders (SSD), have shown limited 
clinical utility in medical settings. There is currently need to develop and evaluate alternative 
assessment strategies to appropriately characterize psychosocial factors in primary care. 
Aims: The aim of this study was to evaluate the incremental information provided by the 
Diagnostic Criteria for Psychosomatic Research (DCPR), in addition to the DSM-5 and 
compared to the SSD, in primary care. 
Methods: Two hundred participants, recruited in a primary care practice, were 
administered the Structured Clinical Interview for DSM-5, the Structured Interview for DCPR 
revised and Paykel's Clinical Interview for Depression. Subjects also completed the Short Form 
Health Survey, the Psychosocial Index and the Illness Attitude Scales. Sub-groups comparisons 
and hierarchical regression analyses were performed to evaluate the associations of DCPR and 
DSM-5 diagnoses with psychological measures.  
Results: DCPR identified psychological distress in the proportion of 4:1 as compared to 
the SSD. The percentage of patients with at least 1 diagnosis rose from 23%, when using solely 
the DSM-5, to 46% when integrating the DCPR. The DCPR showed a greater number of 
significant predictions of dimensional measures of quality of life, well-being, stress, 
psychological distress and illness behavior, compared to SSD. Psychosomatic syndromes had a 
large effect size over and above that of DSM-5. 
Conclusions: The DCPR are superior to the SSD in evaluating psychosocial factors in 
primary care patients. Integration of DCPR in the psychological assessment in primary care 
enhances the clinical utility of the DSM-5. 
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    CHAPTER 1 
Introduction 
 
 
1.1 Rationale for Primary Care Psychology 
 
Psychological problems are highly prevalent in primary care settings (Toft et al., 2005; 
Menchetti et al., 2007; Roca et al., 2009), with an estimated rate of approximately 25-30% 
(Ustun & Sartorius, 1995; Serrano-Blanco et al., 2010). The majority of these patients are 
managed solely by General Practitioners (GPs) and there is evidence that patients with mental 
disorders have a significantly higher rate of contacts with their GPs than those affected only by 
medical disorders (Goldberg & Houxley, 1992; Zantinge et al., 2005). Hence, the management 
of psychological problems represents a significant burden on GPs’ workload (Zantinge et al., 
2005).  
However, psychological problems in primary care remain undertreated and 
underdiagnosed (Van der Brink et al., 1991; Unutzer et al., 1999). Several limitations of GPs’ 
care for mental disorders, such as lack of specific skills and time available per patient, have 
been highlighted (Zantinge et al., 2005). The diagnosis is a major problem as in many patients 
mental health problems manifest themselves in the form of somatic complaints, distracting GPs 
from recognizing psychological problems (Van der Brink et al., 1991; Unutzer et al., 1999; De 
Waal et al., 2004; Löwe et al., 2008). When identified, few patients are referred to secondary 
care services; of those referred for mental health treatment, about one-third fails to make the 
first appointment (Zivin et al., 2009), resisting GPs’ referral (Nutting et al., 2002).  
Various investigations have indicated that a small portion of patients who are treated for 
mental disorders in primary care receive guideline-concordant treatment (Gonzalez et al., 
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2010). Most of these patients receive only pharmacological therapy, characterized by 
inadequate doses and poor compliance (Nutting et al., 2002; Gonzalez et al., 2010). 
Additionally, patients are often reluctant about taking drug treatments and psychological 
therapy is generally preferred (Van Schaik et al., 2006).  
Difficulties in delivering effective treatments may lead to a worsening of mental 
disorders and a further increase of economic costs due to inappropriate use of healthcare 
resources such as GP consultations, drug prescriptions, medical testing and emergency services 
(Bower & Rowland, 2006; König et al., 2009).  
Thus, the current mental health system in primary care fails at multiple levels: identifying 
patients with mental health problems, referring them for appropriate care, assuring follow-
through, and achieving desired outcomes (Thielke, Vannoy & Unutzer, 2007; Mojtabai et al., 
2011). 
 
 
 
1.2 Principles of Primary Care Psychology 
 
The evidence from the literature has shown that usual mental health care implemented in 
general practice has been far from optimal. For this reason, in the recent years, there has been 
an increasing demand across the world for addressing the needs of patients in primary care by 
including psychologists in the provision of integrated services (McDaniel & deGruy, 2014).  
Primary care has been defined as “the provision of integrated, accessible health care 
services by clinicians who are accountable for addressing a large majority of personal health 
care needs, developing a sustained partnership with patients, and practicing in the context of 
family and community” (Institute of Medicine, 1994).  
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Primary care for mental health refers specifically to services that are integrated into 
health care at a primary care level. The World Health Organization defines primary care 
psychology as “the provision of basic preventive and curative mental health care at the first 
point of contact of entry into the health care system” (WHO, 2001).  
This type of care is thus concerned with the application of psychological principles to 
common physical and mental health problems experienced by patients and presented in primary 
care (McDaniel et al., 2014). Essential services at the primary care level include early 
identification and treatment of mental disorders, management of chronic psychiatric conditions, 
referral to other services when required, attention to the mental health needs of people with 
physical health problems and mental health promotion and prevention (WHO, 2008).  
In the provision of integrated services central is the bio-psychosocial model of health and 
disease, which recognizes the complexity of addressing all dimensions of health and illness 
(Engel, 1977). Integrating mental health into general practice includes a person-centered and 
holistic approach, meeting the mental health needs of people with physical disorders, as well as 
the physical health needs of those affected by mental disorders (WHO, 2008).   
Another core feature of integrated primary care is the inter-professional approach to care 
(Derksen, 2009). Primary care psychologists work with physicians and other health 
professionals in a collaborative and coordinated manner, delivering services such as health 
promotion, acute care, chronic disease management and mental health, with the formulation of 
joint treatments and objectives (Croghan & Brown, 2010; Collins et al., 2010; McDaniel & 
deGruy, 2014). Psychologists in primary care contribute from a preventive perspective and 
adopt a community approach to the provision of mental health care. 
Integrating mental health services into primary care may be beneficial for several reasons. 
Mental health services at the primary care level are generally the most accessible, affordable 
and acceptable for communities. Thus, primary care psychology represents an opportunity for 
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reducing the gap between people affected from mental disorders and those receiving 
psychological treatment (Kohn et al., 2004) by increasing access to mental health services close 
to people homes and by providing a continuity of care. 
 
 
 
1.3 Role and duties of Primary Care Psychologists 
 
As McDaniel and de Gruy pointed out (2014), psychologists are in the vanguard for being 
called to take on new roles in primary care; the changes in the field thus open new 
opportunities.  
The contribution of primary care psychologists is wide and aimed at the promotion of 
health. PC psychologists may be involved in the management of mental disorders, but also in 
addressing health behavior change associated with chronic diseases, or tracking progress in the 
care plan (McDaniel & deGruy, 2014). 
An element of characterization of the work of the PC psychologists is the context in 
which he/she operates. Primary care setting is fast moving (short time visits), chaotic (frequent 
changes of schedule), concerned with health and illness, complicated (different health problems 
managed concurrently), team-based (close cooperation with other primary care providers) and 
multimodal (McDaniel & deGruy, 2014). These distinct elements of primary care settings, 
including the diversity of patients with a varied range of problems and their bio-psychosocial 
nature, shape the activities of a PC psychologist.  
With a limited time available per patient, the PC psychologists provides immediate, brief 
and directive support, making use of diagnostic and assessment tools, together with short-term 
interventions (Derksen, 2009).  
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The PC psychologist, like the family physician, is a generalist and thus focuses more at 
gatekeeping for the provision of care, whereas the specialist is focused more at the alleviation 
of symptoms. As to the assessment, the clinical psychologist evaluates the symptomatology 
more precisely, whereas the PC psychologist addresses also the healthy aspects in a global 
point of view.  
With regards to the provision of psychological support, the PC psychologist applies 
particular techniques within a very short period of time, drawing upon different therapeutic 
orientations (McDaniel et al., 2014) and using a stepped care approach. This entails the 
adjustment of the care strategy along the intervention, starting with minimal interventions and 
scaling up to referral to secondary services (Derksen, 2009). Being responsible for the overall 
psychological care means that, after referral for secondary or tertiary care, the patient may 
return to the PC psychologist for follow-up evaluation. The PC psychologist thus serves family 
psychologist and is thus comparable with the family physician for somatic care (Derksen, 
2009). 
 
 
 
1.4 Behavioral Health  
 
Addressing both physical and mental health problems in primary care allows monitoring 
the patient’s overall health status rather than specific symptoms, fostering preventive 
interventions. In light of this consideration, bringing the general population to healthy lifestyles 
would represent an important form of prevention for most prevalent conditions  (Stone, 2004; 
Djoussè, Driver & Graziano, 2009 Forman, Stampfer, & Curhan, 2009; Tomba, 2012). 
Health-related behavior (e.g. overweight, obesity, poor diet and physical activities) is an 
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important determinant of chronic diseases, such as cardiovascular problems and diabetes, with 
a high impact on the course of medical diseases (Yusuf et al., 2004; de Waure et al., 2013). 
Patients with chronic disease are the most frequent conditions typically seen in general practice 
settings. Nonetheless, it has been showed that there is a significant gap between physicians’ 
knowledge and their practices regarding evidence-based recommendations for health promotion 
and disease prevention (Arndt et al., 2002; Brotons et al., 2005).  
Recently, there has been a growing interest in integrating lifestyle counseling and 
behavior change into primary care (Dysinger, 2013; Clarke & Hauser, 2016). It has been 
theorized that, since many patients in primary care present physical symptoms affected by 
stress, problems maintaining healthy lifestyles or a psychological disorder. Therefore, it could 
be clinically effective and cost-effective to make behavioral counseling a core feature of 
primary care psychology (McDaniel et al., 2014).  
A recent systematic review of the literature (Melvin et al., 2017) has highlighted that 
lifestyle and behavioral counseling interventions in primary care were effective in improving 
weight and physical activity-related outcomes, among diverse populations. As to weight loss, 
also web-based and computer-based interventions, which allow patients to have a self-
manageable and tailored weight loss plan, proved to yield significant effects as compared to 
usual care (Bennett et al., 2010). As to physical activity, counseling studies achieved significant 
outcomes when interventions offered more versus less frequent sessions (Volger et al., 2013). 
This review further underlined that no significant effects were found with regards to the 
outcomes associated with diet modification (Melvin et al., 2017). 
Recent effort focuses on using behavioral counseling to identify healthy behaviors and 
lifestyle changes that patients are capable of making within their community context, including 
their social and economic resources.  
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1.5 Models of mental health care in general practice  
 
The discussion in the scientific literature regarding the implementation of psychological 
services in primary care has included the different types of models that might be used for this 
purpose. 
For example, Blount (2003) identifies different types of relationships between mental 
health and medical providers in primary care. The author proposes to distinguish services that 
are coordinated, co-located, and services that are integrated.  
Mental health and primary care providers may work in an independent but coordinated 
care. When services are coordinated, specific information is exchanged on a routine basis when 
patients are in treatment in both settings (Blount, 2003). Furthermore, another designated staff 
member, such as a mental health care manager, might serve as the responsible agent both for 
following up with patients and for communicating between primary care and mental health 
providers  (Thielke, Thompson & Stuart, 2011).  
When services are co-located behavioral health and medical services are located in the 
same site sharing office staff and facilities. Co-location indirectly encourages communication 
between behavioral health and medical providers, enhancing the process of referrals. With this 
model, the problem of patients failing to keep behavioral health appointments is improved but 
not eliminated (Blount, 2003).  
 Integrated care refers to a more structured program for interaction between primary care 
and mental health providers. In particular, integrated care describes care in which there is one 
comprehensive treatment plan with behavioral and medical elements. This model usually 
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makes use of shared formal data tracking systems, monitoring patient symptoms and 
treatments, care plans, and communications with patients and between providers (Thielke et al., 
2011).  
An example of integrated care is the Patient-Centered Medical Home (PCMH). PCMHs 
represent a transition toward an innovative approach of care that is patient and family oriented, 
comprehensive (integrating both behavioral and physical health needs), coordinated across 
providers and easy to access. In 2010, the government of the U.S. passed into legislation the 
Patient Protection and Affordable Care Act (ACA), with the aim of ensuring general access to 
quality, affordable and integrated healthcare.  This legislation fostered an organizational 
structure built upon inter-professional healthcare practice, termed the PCMH (Kaslow et al., 
2015). Psychologists have been called to play an important role in PCMH team (McDaniel & 
deGruy, 2014). However, evidence showed that less than 50% of PCMHs include a 
psychologist in the provision of services (Kessler et al., 2014). For this reason, the Working 
Party Group on Integrated Behavioral Health Care (Baird et al., 2014) recognized that 
comprehensive whole-person care was not being achieved and thus called for a greater 
integration. 
In the Netherlands, since 1970 psychologists started working in collaboration with 
general practitioners. From 2008, the government recognized the professional figures of PC 
psychologists. A total of eight consults is reimbursed as part of every basic health insurance 
policy for every Dutch inhabitant, which might be increased up to 12 consults (Derksen, 2009). 
The PC psychologist is a certified health psychologist, working as a generalist with specialized 
primary care skills. In particular, the PC psychologist is able to assess and manage in 
collaboration with the GP a full range of psychological and behavioral problems occurring in 
individuals and families. The PC psychologist usually practices in the same setting with one or 
more family physicians (Derksen, 2009). 
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In the Italian context, the Primary Care Psychologist is not a recognized profession. 
According to the literature, there have been few initiatives, at the local level, which aimed at 
implementing some types of psychological service in general practice settings. The most 
notable intervention has been carried out by Solano (2011) in Rome. The service, which has 
been active for more than ten years, consists of a co-presence of both the medical practitioner 
and the psychologist in the same office, twice a week.  
 
 
 
1.6 Prevalence of psychological distress in primary care 
 
The evidence from the literature indicates that mental and behavioral disorders are 
common among patients attending primary health care settings.  
The large cross-cultural study conducted by WHO in 14 countries (Üstün & Sartorius 
1995) showed that, although the prevalence of mental disorders across the sites varied 
considerably, an average of 24% of all patients in these settings had a mental disorder. 
Prevalence ranged from 7.3% in China to 52.5% in Chile; the most frequent diagnoses were 
depressive, anxiety, and substance-related disorders.  
King and colleagues (2008) assessed major depression, panic syndrome and other anxiety 
syndromes in general practice of 6 different European countries. The results showed that 
prevalence of major depression, other anxiety syndrome and panic syndrome in people 
attending their general practitioners was high but varied significantly between countries, with 
the highest prevalence in the UK and Spain, and lowest in The Netherlands and Slovenia.  
A cross-sectional study carried out in Denmark (Toft et al., 2005) found a very high 
prevalence of ICD-10 mental disorders in primary care among patients consulting for a new 
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health problem, reaching about 50% at inclusion. Somatoform disorder (36%) was the most 
prevalent group of disorders. Similarly, a large study epidemiological study in primary care 
carried out in Spain (Roca et al., 2009) found a prevalence of psychiatric disorders of 53.6%. 
This prevalence was higher than in most of the studies, especially with regard to major 
depressive disorder, with a prevalence of 29%.  
In Italy, a lower prevalence of mental disorders has been reported in comparison to other 
countries. The studies have reported a prevalence of around 12% for formal psychiatric 
disorders and a range from 11% to 18% for sub-threshold disorders (Menchetti et al., 2007). 
These disorders, primary depressive and anxiety disorders, were not associated with physical or 
medical conditions but mainly with disabilities and socio-economic problems. 
 
 
 
1.3 Efficacy and cost-effectiveness of psychological treatment in primary 
care 
 
Different studies have been carried out in order to evaluate the efficacy and cost-
effectiveness of psychological treatments in primary care. With resources being limited, 
psychological therapy provided within primary care settings for mental disorders is brief, often 
consisting of less than ten sessions (Cape et al., 2010). Randomized controlled studies in 
primary care have targeted depression and anxiety as the main focus of psychological 
interventions, being the most common mental disorders. These studies have included guided 
self-help interventions (i.e. bibliotherapy and computerized treatments) and brief therapies such 
as counseling (a generic approach used to develop self-knowledge, emotional acceptance and 
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growth), problem-solving and cognitive behavioral therapies – CBT. All treatments proved to 
obtain a significant reduction in symptoms of depression and anxiety in the short term, as 
measured by standardized tests, in comparison to GPs’ usual care or no care (Bower, Richards 
& Lovell, 2001; Bortolotti et al., 2008; Cape et al., 2010; Høifødt et al., 2011; Wells et al., 
2018).  Furthermore, these treatments were generally found to produce approximately equal 
benefits and no particular approach significantly outperformed any other (King et al., 2008; 
Cape et al., 2010; Høifødt et al., 2011).  
These interventions seem to be effective when supported by either healthcare workers 
such as general practitioners and primary care staff (e.g. nurses) or psychologists and 
accredited counselors (Høifødt et al., 2011). However, a meta-analysis on the treatment of 
medically unexplained symptoms in primary care found that psychological interventions 
delivered by psychotherapists had larger effects than those provided by GPs (Gerger et al., 
2015). 
General short-term positive effects of brief psychological treatment have been confirmed 
by different meta-analysis (Bortolotti et al., 2008; Cujipers et al., 2009; Cape et al., 2010). The 
effect size found for such treatments were relatively smaller compared to the results of 
treatments carried out in other settings such as specialized mental health care, involving a 
longer duration of psychological therapies (Cujipers et al., 2009; Cape et al., 2010). This 
difference could be due to the less severe conditions presented by primary care patients, 
compared to those in secondary care, which would therefore limit the potential effect size 
(Cape et al., 2010).  
Evidence about the long-term efficacy is more equivocal. Different studies found a lack 
of significant difference between the brief psychological therapy groups and usual care at 12 
months or more (King et al., 2000; Simpson et al., 2000; Barrowclough et al., 2001; Murray et 
al., 2003). However, some studies found that the effects of brief therapy, such as counseling, 
 17 
were maintained in the long period, up to two years (Gordon & Graham, 1996; Baker et al., 
1998). A meta-analytic review by Bortolotti and co-workers (2008) did report significant short-
term and long-term significant differences between psychological interventions and usual care 
in reducing symptoms of depression. Furthermore, psychological treatments appeared to be 
equivalent to antidepressants both in the short and long-term. King (2000) showed that in his 
study the lack of a significant difference between the treatment groups in the long-term resulted 
from greater improvement of patients in the GP care group between the 4 and 12-month follow-
ups. Hence, the continuation of GPs usual care, unlike the psychological intervention that is 
interrupted, could have a role in the differences observed in the long-term. Such evidence 
points out the need for further research on long-term efficacy of brief psychological therapies 
before conclusions can be drawn (Bower and Rowland, 2006).  
Given that mental health problems are related to an increased use of primary medical care 
services, it has been suggested that the implementation of psychological interventions might 
result in an overall decrease in medical care costs and cost offset (Bower and Rowland, 2006). 
This might include fewer referrals to psychiatric services, reduction of drug prescriptions and 
less GP and hospital consultations. A review by Bower and Rowland (2006) suggested that 
counseling in primary care was associated with a reduction in health service utilization, 
especially GP consultations, in comparison to usual care. The overall costs of the two 
treatments were similar. Thus, it seems that the addition of psychological interventions in 
primary care does not increase health care costs.  
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CHAPTER 2 
 
     Psychological assessment in primary care 
 
 
2.1 Introduction 
 
The prevalence of mental illnesses, their manifestations and their comorbidity are a major 
issue in primary care. The responsibility for the initial diagnosis of mental disorders falls on 
primary care, the first point of contact for patients within the health system (Roca et al., 2009).  
Furthermore, psychological assessment in primary care should include evaluation of 
psychosocial factors such as lifestyle behaviors, social support and stress (Derksen, 2009). 
Thus, a comprehensive assessment of psychosocial distress in primary care patients is a core 
aspect of the work of a PC psychologist (Bower & Gilbody, 2005; McDaniel et al., 2014).  
The assessment process may be undertaken by the PC psychologist after screening from 
the GP and should rapidly provide the information needed to identify the patient’s concerns 
(Derksen, J. 2009; McDaniel et al., 2014).  According to Derksen (2009), the PC psychologist 
can generally treat with success those conditions where the relevant complaints have appeared 
for the first time, have not existed for a long period of time, have shown an acute emergence, 
have appeared as a reaction to an identifiable stressor, and have not been diagnosed in 
conjunction with a severe personality disorder. When the intake shows one or more of the 
aforementioned criteria to not be met or an unclear situation to present itself, then more 
extensive psychodiagnostic screening may be undertaken by the PC psychologist. Based on 
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these clinical indications, the psychologist should develop a plan to address the patient’s needs 
(e.g. determine whether short-term assistance or referral to a specialist is appropriate) (Derksen, 
2009; McDaniel et al., 2014).  
To examine the patient, the PC psychologist may draw upon a broad range of assessment 
strategies, such as non-structured clinical interviews and administration of psychological tools. 
Examples of tests that are frequently used include the Minnesota Multiphasic Personality 
Inventory (MMPI-2), the Millon Clinical Multiaxial Inventory (MCMI-III), the Rorschach 
inkblot test, and instruments to assess specific types of complaints, such as the Beck 
Depression Inventory (BDI) (Kush, 2001; Derksen, 2009). 
Additionally, in the diagnostic process PC psychologists make particular reference to 
psychiatric classifications such as the Diagnostic and Statistical Manual of Mental Disorders- 
DSM, now fifth edition (Derksen, 2009; APA, 2013). The DSM is specifically used in clinical 
practice to discern, in the clinical reasoning, between complex and less complex disorders, in 
order to decide for a referral to secondary service or a management of the condition in primary 
care (Derksen, 2009). 
Due to the under-detection of mental disorders in primary care, a significant amount of 
attention has been paid by research studies to enhance recognition of psychiatric disorders 
among patients. Tools that have been developed for this purpose include the Patient Health 
Questionnaire- PHQ (Spitzer et al., 1994; Spitzer et al., 1999), the General Health 
Questionnaire- GHQ (Goldberg, D. 1972) and the Symptom Check-list- SCL-90 (Derogatis, 
1977). These questionnaires screen the symptoms that are the basis of DSM criteria and once 
an appropriate cut-off point has been chosen, they can be used as screening devices for the 
detection of psychological distress. Generally, these tools have proved to be valid instruments 
to detect mental disorders in primary care (Schmitz et al., 1999; Spitzer et al., 1999).  
However, an assessment based solely on instruments that refer to psychiatric 
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psychopathology has the potential risk of neglecting psychosocial factors, which are functional 
to a comprehensive psychological assessment and consistent with the philosophy of integrated 
primary care. 
 
 
2.2 Limitations of the DSM-5 
 
In the last years, there have been increasing concerns regarding the clinical utility of 
DSM in clinical practice (Guidi et al., 2013; Cosci & Fava, 2016).  
A major limitation of the DSM-5 is that it fails to appropriately detect mild mental 
disturbances and sub-threshold symptoms, which are often expressed in the form of somatic 
complaints (Fink et al., 2005; Hanel et al., 2009).  
Previously, these complaints were addressed by the DSM in the category of somatoform 
disorders. In the last years, the issue of physical versus psychiatric has given rise to an 
important debate (Sykes, 2006; Rief & Isaac, 2007) and a group of experts (Bass, Preveler & 
House, 2001) have proposed abolishing the whole category of somatoform disorders from the 
DSM-IV. Others have underlined its inadequacy for primary care use (Fink et al., 2005; 
Rosendal et al., 2005).  
In the new DSM-5, the category of somatoform disorders has been changed into the 
category called “somatic symptom and related disorders” (APA, 2013). This category includes 
the diagnoses of somatic symptom disorder, illness anxiety disorder, conversion disorder, 
psychological factors affecting other medical conditions, factitious disorder, other specified 
somatic symptom and related disorder, and unspecified somatic symptom and related disorder. 
According to the DSM-5, these disorders share as a common feature the prominence of somatic 
symptoms associated with significant distress and impairment.  
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Cosci and Fava (2016) have highlighted specific limitations that each of these singles 
rubrics entail. 
The main diagnosis, somatic symptoms disorder, requires one or more distressing somatic 
symptoms and excessive thoughts, feelings, and behaviors related to these symptoms or 
associated health concerns (APA, 2013). However, medically unexplained symptoms do not 
necessarily involve excessive anxiety about the seriousness of symptoms but might induce 
demoralization and irritability (Cosci & Fava, 2016).  
The diagnosis of illness anxiety disorder is concerned with the preoccupation of having or 
acquiring a serious illness, without the presence of high intensity somatic symptoms and 
maladaptive health-seeking behavior (APA, 2013). The potential problem, in this case, is the 
overlapping criteria with the category of somatic symptom disorder (Cosci & Fava, 2016). 
 In conversion disorder, the essential feature is neurological symptoms that are 
incompatible with neurological pathophysiology (APA, 2013). However, about 30% of 
outpatients who attend neurological facilities have symptoms not explained by medical findings 
(Stone et al., 2009).  
The essential feature of psychological factors affecting other medical conditions is the 
presence of clinically significant psychological or behavioral factors that adversely affect a 
medical condition by increasing the risk for suffering, death, or disability (APA, 2013). These 
factors are poorly specified and add little to the diagnostic process.  
As Cosci and Fava (2016) pointed out, in addition to the ambiguities of these single 
diagnostic rubrics, there are additional limitations that may result in misleading clinical 
indications. One is concerned with the use of the term “somatic symptom”, which reflects the 
fact that anything that cannot be explained by organic causes will fall within the domains of 
somatization. Thus, the DSM-5 maintains the dichotomy organic/functional, which is based on 
the assumption that if somatic symptoms cannot be explained by organic factors, there should 
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be psychiatric reasons explaining this symptomatology.  
Another major flaw of the DSM-5 is that this customary taxonomy does not include 
important clinical information such as severity and pattern of symptoms, aspects of daily life 
(e.g. well-being, quality of life and stress) and illness behavior (i.e. the ways in which 
individuals experience, perceive, evaluate and respond to their own health status) (Mechanic & 
Volkart, 1960; Fava, Rafanelli & Tomba, 2012; Cosci & Fava, 2016).  
 
 
 
2.3 The DCPR: an alternative categorical classification for primary care 
 
It has been proposed that the assessment of psychosocial distress in medical settings such 
as primary care could benefit from the refinement of diagnostic instruments with high 
sensitivity, able to reveal sub-threshold symptomatology and to identify patterns of illness 
behaviors (Fava et al., 2007; Sirri et al., 2011; Fava, Sonino & Wise, 2012). 
The Diagnostic Criteria for Psychosomatic Research- DCPR (Fava et al., 1995; Cosci & 
Fava, 2016) may represent an example of such tools. The DCPR are a set of syndromes that 
allows translation of the spectrum of manifestations of illness behavior and sub-threshold 
distress in clinical terms and can be applied to both psychiatric and medical illnesses (Cosci & 
Fava, 2016).  
Recently, the DCPR have been presented in the revised version (Fava et al., 2017). They 
now include 14 psychosomatic syndromes.  One is concerned with stress (allostatic overload), 
two with personality (Type A behavior and alexithymia), eight of them refer to the concept of 
abnormal illness behavior (persistent somatization, conversion symptoms, anniversary reaction, 
disease phobia, thanatophobia, health anxiety, illness denial and hypochondriasis) and three 
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syndromes (i.e. demoralization, irritable mood and secondary somatic symptoms) can be 
considered psychological manifestations of affective disturbances. Table 1 outlines the new 
DCPR criteria as presented by Fava and colleagues (2017). 
Allostatic overload occurs when the cost of chronic exposure to stress-related fluctuating 
and heightened neural or neuroendocrine responses exceeds the coping resources of an 
individual (Fava et al., 2010). It is characterized by fatigue, psychic anxiety, irritability, and 
initial insomnia. 
Type A behavior is the other DCPR irritability syndrome that has been recognized in 
those at risk of coronary heart disease (Friedman & Rosenman, 1974) but was also found in 
10.8% of patients with non-cardiac diseases, suggesting the need to extend its assessment to 
other medical settings (Sirri et al., 2012).  Type A behavior may share some features with 
hypomania, cyclothymia, and hyperthymic temperament which frequently results in an 
overoptimistic view of one’s own ability to cope with a stressful situation (as is a life-
threatening disease) and in the minimization of vulnerability to future difficulties (e.g. medical 
complications) (Wang et al., 2011). 
Alexithymia characterizes patients who have difficulties in describing feelings and 
differentiating them from bodily sensations, a poor fantasy life, and an “operative” way of 
thinking. 
The diagnosis of hypochondriasis was retained from the DSM-IV classification, as 
psychotherapeutic strategies had been developed and validated in randomized controlled trials 
(Fava et al., 2000; Barsky & Ahern, 2004) to address resistance to reassurance, which is the key 
characteristic of hypochondriasis.  
Health anxiety includes a wide range of worries towards illness and pain, which are less 
specific than hypochondriasis and disease phobia and respond to medical reassurance.  
Thanatophobia and disease phobia may be components of a hypocondriacal syndrome, 
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yet they may also occur independently. Disease phobia differs from hypochondriasis for the 
specificity, longitudinal stability and quality of the phobia, which concerns a specific disease, it 
is unlikely to be moved on another disease and tend to manifest itself in attacks rather than in 
constant worries. Both disease phobia and health anxiety were found to be prevalent in 
consultation-liaison psychiatry patients (Galeazzi et al., 2004; Porcelli et al., 2009). 
Persistent somatization refers to patients in whom somatic symptoms have clustered. It 
may occur regardless of the functional/organic dichotomy and may be associated to a variety of 
medical disorders (Porcelli and Guidi, 2015). 
The DCPR defined conversion symptoms were formulated according to Engel’s (1970) 
criteria.  In a sample of patients from various medical settings, DCPR conversion symptoms 
were found in 4.5% of subjects, while DSM-IV conversion disorder in only 0.4% (Porcelli et 
al., 2012). 
The anniversary reaction is a special form of somatization or conversion where symptoms 
are related to the occurrence of the anniversary of a meaningful event the person’s life. This 
diagnosis showed a prevalence of 3.6% in patients from different medical settings (Porcelli et 
al., 2012). 
Illness denial includes patients who do not acknowledge the presence or the severity of 
their illness. In healthy subjects, illness denial may concern one’s own vulnerability to life-
threatening diseases, resulting in unsafe health habits or non-attendance to preventive 
screenings (Fava et al., 2017).  DCPR illness denial was found in 9% of women with breast 
cancer (Grassi et al., 2005) and in 5% of subjects who underwent heart transplantation (Grandi 
et al., 2011). 
The definition of demoralization integrates Frank’s (1961) demoralization syndrome and 
Schmale and Engel’s (1967) giving up–given up complex.  According to de Figueiredo (2013) 
demoralization results from the convergence of psychological distress (helplessness and 
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hopelessness) and subjective incompetence (being unable to cope with a stressful situation).  
The syndrome of irritable mood is based on Snaith and Taylor’s (1985) definition. It is 
characterized by a feeling state that might be experienced as brief episodes or be prolonged and 
generalized, or need an increased effort of control over irritability. The experience of irritability 
is always unpleasant for the individual, and its overt manifestation lacks a cathartic effect 
(Snaith & Taylor, 1985).  
The syndrome of functional somatic symptom secondary to a psychiatric disorder 
concerns the hierarchical relationship between functional somatic symptoms and psychiatric 
disorders. Symptoms of autonomic arousal may be a consequence of psychiatric disorders 
(Fava et al., 2017). 
According to a recent review (Porcelli & Guidi, 2015), the DCPR can be clinically useful 
for different reasons. 
Sub-typing medical patients: DCPR syndromes may be used for sub-typing patients who 
are characterized by distinct psychological profiles, even though present with the same 
diagnosis. Sub-typing helps clinicians to tailor different decision and interventions based on the 
psychological characteristics of a given individual (Porcelli & Guidi, 2015). DCPR were useful 
for sub-typing patients with a psychiatric diagnosis (Fava et al., 2012) or a medical disease, 
such as hypertension (Rafanelli et al., 2012). 
Identifying sub-threshold or undetected syndromes: DCPR allows identification of 
psychopathological conditions that either have subclinical manifestations not meeting 
diagnostic criteria for psychopathology or are completely ignored by traditional nosography.  
Evaluating the burden of somatic syndromes: Psychopathology and psychosocial distress 
increase the burden of illness in the medically ill.  The DCPR system has been used in a variety 
of medical settings, giving clinicians the possibility to identify the patients at a higher risk of 
distress because of their elevated burden of disease.  
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Predicting treatment outcomes and identifying risk factors: identifying the psychosocial 
variables influencing the treatment outcome is useful in clinical practice because it may help 
the identification of patients who are more likely to not respond to standard medical treatment.  
In patients with moderate-to-severe functional gastro-intestinal disorder, nonresponse to 
treatment was significantly and independently predicted by the DCPR syndromes of 
alexithymia and persistent somatization, while improvement after treatment was predicted by 
DCPR health anxiety (Porcelli, De Carne & Todarello, 2004).  
The DCPR have been compared to the DSM-5 in few studies. In a study on patients with 
congestive heart failure, Guidi and co-workers (2013) demonstrated that the DCPR-based 
proposal allowed a significant higher identification of psychological factors meaningful for the 
illness course when compared with the newly proposed DSM-5 diagnostic criteria for somatic 
symptom disorders. Furthermore, the DCPR predicted a worse psychosocial functioning, in 
psychiatric patients, compared to the DSM-5 (Porcelli et al., 2009). 
The clinical utility of DCPR for primary care practice is yet to be fully understood. A 
study by Ferrari and co-workers (2008) found a greater severity of DCPR syndromes (number 
of syndromes a patient has) among frequent attenders in primary care, compared to average 
attenders, suggesting a mediating role of DCPR syndromes in promoting this behavioral 
pattern. There is currently need to evaluate the ability of DCPR to detect and characterize 
psychosocial distress and global functioning in primary care. 
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Table 1. Revised DCPR Criteria (Fava et al., 2017) 
Allostatic overload: presence of a current identifiable source of distress in the form of recent 
life events and/or chronic stress; the stressor is judged to tax or exceed the individual’s coping 
skills when its full nature and circumstances are evaluated.  
The stressor is associated with 1 or more of the following 3 features, which have occurred 
within 6 months after the onset of the stressor:  
(1) At least 2 of the following symptoms: difficulty falling asleep, restless sleep, early 
morning awakening, lack of energy, dizziness, generalized anxiety, irritability, sadness, 
demoralization.  
(2) Significant impairment in social or occupational functioning.  
(3) Significant impairment in environmental mastery (feeling overwhelmed by the demands of 
everyday life) 
Type A behavior: At least 5 of the 9 following characteristics should be present: excessive 
degree of involvement in work and other activities subject to deadlines; steady and pervasive 
sense of urgency; display of motor-expressive features (rapid and explosive speech, abrupt 
body movements, tensing of facial muscles, hand gestures) indicating a sense of being under 
pressure of time; hostility and cynicism; irritability; tendency to speed up physical activities; 
tendency to speed up mental activities; high desire for achievement and recognition; high 
competitiveness. 
Alexithymia: At least 3 of the following 6 characteristics are present: inability to use 
appropriate words to describe emotions; tendency to describe details instead of feelings; lack 
of a rich fantasy life; thought content associated more with external events than with fantasy 
or emotions; unawareness of the common somatic reactions accompanying the experience of 
a variety of feelings; occasional but violent and often inappropriate outbursts of affective 
behavior. 
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Hypochondriasis: Fears of having, or the idea of having, a serious disease based on 
misinterpretation of bodily symptoms. The preoccupations persist despite adequate medical 
evaluation and reassurance, with opportunity for discussion and clarification. The duration of 
the disturbance is at least 6 months. The preoccupations cause marked distress and/or 
impairment in social and occupational functioning.  
Disease phobia: A persistent, unfounded fear of suffering from a specific disease, with doubts 
remaining despite adequate examination and reassurance. Fears tend to manifest themselves 
in attacks rather than in chronic worries as in hypochondriasis; panic attacks may be 
associated. The object of fears does not change with time. Duration of symptoms exceeds 6 
months. 
Thanatophobia: At least 2 attacks in the past 6 months of impending death and/or conviction 
of dying soon, without being in a threatening situation or in real danger; adequate appraisal of 
the situation and management to be followed (if any) has been provided by a physician, with 
an opportunity for discussion and clarification.  
Marked and persistent fear and avoidance of news that reminds of death (e.g. funerals, 
obituary notices); exposure to these stimuli almost invariably provokes an immediate anxiety 
response Avoidance, anxious anticipation, and distress interfere markedly with the level of 
functioning. 
Health anxiety: Generic worry about illness, concern about pain and bodily preoccupations, 
tendency to amplify somatic sensations of less than 6 months’ duration. Worries and fears 
readily respond to appropriate medical reassurance, even though new worries may ensue after 
some time. 
Persistent somatization: Functional medical syndromes (fibromyalgia, chronic fatigue, 
esophageal motility disorders, nonulcer dyspepsia, irritable bowel syndrome, atypical chest 
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pain, overactive bladder) whose duration exceeds 6 months causing distress and/or seeking 
medical care and/or resulting in impaired quality of life.  Symptoms of autonomic arousal 
involving other organ systems (e.g. palpitations, tremor, flushing, sweating) and/or 
exaggerated side effects from medical therapy, indicating low threshold of pain sensation 
and/or high suggestibility. 
Conversion symptoms: One or more symptoms/deficits affecting voluntary motor/sensory 
function, characterized by lack of anatomical or physiological plausibility; and/or absence of 
expected physical signs or laboratory findings; and/or inconsistent clinical characteristics. If 
symptoms of autonomic arousal or a functional medical disorder are present, conversion 
symptoms should be prominent, causing distress or repeated medical care or impairing quality 
of life. At least 2 of the following features are present: ambivalence in symptom reporting; 
histrionic personality features; precipitation of symptoms by psychological stress, the 
association of which the patient is unaware; history of similar physical symptoms experienced 
by the patient or observed in or wished on someone else. 
Anniversary reaction: Symptoms of autonomic arousal (e.g. palpitations, tremor, flushing, 
sweating) or functional syndromes (e.g. irritable bowel syndrome, fibromyalgia, atypical 
chest pain) or conversion symptoms causing distress and/or seeking medical care and/or 
impaired quality of life Appropriate medical evaluation uncovers no organic pathology to 
account for physical symptoms. Symptoms began when the patient reached the age, or on the 
occasion of the anniversary, when a parent or very close family member developed a life-
threatening illness and/or died; the patient is unaware of such association. 
Illness denial: Persistent denial of having a physical disorder and needing treatment (e.g. lack 
of compliance, delayed seeking of medical attention for serious and persistent symptoms, 
counterphobic behavior) as a reaction to the symptoms, signs, diagnosis, or medical treatment 
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of a physical illness. The patient has been provided with an adequate appraisal of the medical 
situation and management (if any) to be followed, with opportunity for discussion and 
clarification. 
Demoralization: A feeling state characterized by the perception of being unable to cope with 
some pressing problems and/or of lack of adequate support from others (helplessness); the 
individual maintains the capacity to react The feeling state is prolonged and generalized 
(duration of at least 1 month). A feeling state characterized by the consciousness of having 
failed to meet expectations associated with the conviction that there are no solutions for 
current problems and difficulties (hopelessness). 
Irritable mood: A feeling state characterized by irritability which may be experienced as 
brief episodes (in particular circumstances) or may be prolonged and generalized; it requires 
an increased effort of control over temper or results in irascible verbal or behavioral 
outbursts The experience of irritability is always unpleasant, and overt manifestations lack the 
cathartic effect of justified outbursts of anger.  
Somatic symptoms secondary to a psychiatric disorder:  Somatic symptoms that cause 
distress and/or seeking medical care and/or impaired quality of life Appropriate medical 
evaluation uncovers no organic pathology to account for the physical complaints. A 
psychiatric disorder (which includes somatic symptoms within its manifestations) preceded 
the onset of somatic symptoms (e.g. panic disorder preceding cardiac symptoms).  
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2.4 Psychosomatic assessment 
 
 In light of the need to promote integrated primary care principles, the psychosomatic 
perspective might represent an important opportunity to foster this new paradigm in primary 
care. 
Psychosomatic medicine is an interdisciplinary field that is concerned with the interaction of 
biological, psychological and social factors in the regulation of the balance between health and 
disease (Lipowski, 1986; Fava & Sonino, 2000; Fava & Sonino, 2005; Fava & Sonino, 2010).  
It is characterized by a personalized and holistic approach to the patient, with the addition of 
psychosocial assessment to the standard medical examination; a multidisciplinary organization 
of health care that overcomes the boundaries of traditional medical specialties; a focus on the 
role of psychosocial factors affecting individual vulnerability, course, and outcome of any type 
of medical disease (Fava et al., 2017).   
Assessment of psychosocial factors potentially influencing individual vulnerability to illness 
is often omitted by the primary care physician or the medical specialist (Fava & Sonino, 2010). 
Moreover, these psychosocial factors are neglected by customary psychiatric taxonomy, which 
tends o rely exclusively on ‘hard data’, excluding ‘soft information’ (Sonino & Fava, 2007). 
For this reason, the notion of psychiatric disturbance is not representative of the complexity of 
the problems encountered in clinical practice (Fava et al., 2004).  
 Psychosocial variables affecting illness vulnerability may encompass factors such as 
psychological distress, stress, illness behavior, well-being and quality of life.  
The notion of stress allows the identification of temporal relationship between life events, 
chronic conditions and symptom onset or relapse. Indeed, daily life stresses may be 
experienced by the individual as taxing or exceeding his/her coping skills. Stress may result in 
responses mediated by a variety of neurotransmitters, proinflammatory cytokines, and 
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hormones  (Grippo & Sotti, 2013; Nemeroff, 2016). 
Illness behavior is a core characterization in psychosomatic medicine and provides an 
explanatory model for clinical phenomena that do not find room in customary taxonomy (Cosci 
& Fava, 2016). Illness behavior refers to the different ways individuals respond to bodily 
indications, monitor internal states, define and interpret symptoms, utilize various sources of 
informal and formal care (Mechanic, 1995). 
Psychological well-being is another crucial factor and several studies have suggested that 
positive affect plays a buffering role in coping with stress and has a favorable impact on disease 
course (Pressman & Cohen, 2005; Ryff et al., 2014).  Frederickson and colleagues (2015) 
showed that individuals with high psychological well-being presented reduced gene expression 
of conserved transcriptional response to adversity, suggesting a potential protective role of 
psychological well-being in a number of medical disorders.  
Quality of life and patient reported outcomes (any report coming directly from patients 
about how they function or feel in relation to a health condition or its therapy) concern the 
functional status of the individual and the patient’s appraisal of his/her own health. Measures of 
disease status alone are insufficient to describe the burden of illness whereas subjective health 
status is as valid as that of the clinician when it comes to evaluating outcomes (Topp et al., 
2015; Rodriguez-Urrutia et al., 2016). 
The psychosomatic evaluation of these important psychosocial variables stems from 
clinimetric principles (Fava, Tomba & Sonino, 2012; Tomba & Bech, 2012; Grassi et al., 2015; 
Bech, 2016; Piolanti et al., 2016). The term ‘clinimetrics’ was introduced by Alvan R. Feinstein 
to indicate a domain concerned with indexes, rating scales, and other expressions that are used 
to describe or measure symptoms, physical signs, and other clinical phenomena (Feinstein, 
1987). The aim of clinimetrics was to provide a home for a number of clinical phenomena 
which did not find room in customary clinical taxonomy (Feinstein, 1987). The customary 
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taxonomy does not include patterns of symptoms, severity of illness, effects of comorbid 
conditions, timing of phenomena, rate of progression of illness, functional capacity and other 
clinical features that demarcate major prognostic and therapeutic differences among patients 
who otherwise seem deceptively similar, because they have the same diagnosis (Feinstein, 
1983). 
The need to include clinimetric consideration of psychosocial factors has emerged as a 
crucial part of clinical investigation and patient care (Feinstein, 1994). This information may be 
crucial in managing  patients with unexplained somatic symptoms (Katon & Walker, 1998) or 
with difficult patient-doctor relationships (Hahn et al., 1994). A comprehensive psychological 
assessment in primary care should thus include a clinimetric evaluation of these psychosocial 
factors. 
 
 
 
2.5 Clinimetric methods and indexes 
 
Clinimetric principles should guide the selection of methods to be used for a specific 
assessment and the modalities in which the assessment unfolds (Fava, Tomba & Sonino, 2011).  
Standardization and sensibility are both related to the quality of clinical measurements 
(Feinstein, 1987). Standardization refers to the reliability and validity of an index. Reliability 
has an external part (observer variability in using the index, such as inter-rater agreement) and 
an internal part (consistency). Validity, on the other hand, reflects the accuracy with which the 
phenomenon under observation is measured with a standard reference procedure, or gold 
standard (Feinstein, 1987). An index is valid if it measures what it is supposed to measure.  
Furthermore, Feinstein (1987) formulated the concept of sensibility. An essential 
 34 
requisite for sensibility of an index is its discrimination properties, which means that it should 
be able to detect clinically relevant changes in health status over time (Husted et al., 2000; Fava 
& Belaise, 2005). Sensibility thus appears an important concept for developing and selecting 
indexes to monitor changes in clinical trials. As important is the clinimetric concept of 
incremental validity, that refers to the unique contribution (or incremental increase) in 
predictive power associated with a particular assessment procedure in the clinical decision 
process (Sechrest, 1963). Accordingly, each distinct aspect of measurement should deliver a 
unique increase in information to qualify for inclusion. In clinical research, several scales are 
often used under the misguided assumption that nothing will be missed. On the contrary, 
violation of the concept of incremental validity leads to conflicting results (Fava & Belaise, 
2005).  
A unique feature of clinimetric tools is to provide a broad global rating of clinical 
phenomena. Although the sensitivity of these methods is acknowledged in drug trials, where 
they often yield the most sensitive discrimination between drug and placebo effects (Fava, 
Rafanelli & Tomba, 2011), their value in clinical practice is currently underestimated.  
Another key characteristic is the collaboration of the patient. This is particularly true in 
the psychosocial domain, where many observer and self-rating scales have been developed. 
Although observer-rated methods make full use of the clinical experience and comparison 
potential of the interviewer, self-rating methods allow a more direct assessment of the patient 
subjective perceptions, such as quality of life.  
Several clinimetric instruments have been developed for the psychological assessment in 
medical settings (Fava, Tomba & Sonino, 2012; Sirri et al., 2008; Piolanti et al., 2016; Fava et 
al., 2017) and might result particularly useful for Primary Care Psychologists. 
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CHAPTER 3 
 
 
Study 
    
   
3.1 Rationale 
 
The current psychiatric taxonomy applied in primary care has limited clinical utility, as it 
fails to detect sub-clinical distress and neglect important psychosocial information necessary 
for the clinical process of medical decisions. In particular, the DSM-5 category of somatic 
symptoms and related disorders has been deemed inadequate for clinical practice use. 
The assessment of psychosocial distress in medical settings such as primary care may 
benefit from the use of the DCPR, allowing the PC psychologist to sensitively reveal sub-
threshold symptomatology. The fact that DCPR may be used for sub-typing medical patients, 
identifying sub-threshold or undetected syndromes, evaluating the burden of somatic 
syndromes, predicting treatment outcomes and identifying risk factors, could enhance the 
clinical utility of the current psychiatric assessment applied in primary care. 
The use of rating scales in primary care represents another major issue. Beside general 
recommendations about available tools to be used in primary care, no studies have been 
conducted to identify a systematic strategy of assessment. The use of self-rating dimensional 
measures of psychosocial factors such as stress, well-being, illness behavior and quality of life 
may provide important information for the process of clinical reasoning. 
Given this background, it is imperative to develop an alternative psychological 
assessment strategy of psychosocial factors for primary care settings. 
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3.2 Aims and objectives 
 
The current study has the main aim to develop and evaluate an alternative psychological 
assessment strategy to appropriately characterize psychosocial factors in primary care patients. 
In particular, this project will attempt to provide an answer for the following research question: 
“Can the DCPR help the psychologist providing appropriate feedback and clinical indications 
in primary care, in conjunction with the DSM-5?”. 
This aim will be subdivided into the following specific objectives:  
1. Report the prevalence of psychosomatic (DCPR) and psychiatric (DSM-5) 
diagnoses in primary care. 
2. Compare DCPR and DSM-5 diagnostic sub-groups with unaffected patients as to 
observer-rated measures of affective symptoms and self-rating dimensions of 
distress, stress, well-being, illness behavior and quality of life. 
3. Evaluate and compare the incremental validity of DCPR and SSD in addition to 
the DSM-5 with regards to self-rated psychological variables. 
 
 
 
3.3 Hypotheses 
 
1. We hypothesize to find prevalence rates of mental disorders similar to those 
reported in the literature. As to the DCPR, we hypothesize that these 
psychosomatic syndromes will allow a sensitive identification of psychological 
sub-threshold distress. 
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2. We hypothesize to find significant higher associations between patients affected 
by a mental or psychosomatic syndromes and dimensional measures of 
psychosocial factors, compared to the unaffected patients. 
3. We hypothesize to find a better prediction of self-related measures of 
psychosocial variables by using the DCPR-based categorization, than the category 
of somatic symptoms disorders, in addition to the DSM-5 diagnostic criteria. 
 
 
 
3.4 Methods 
This study received approval from the ethics boards of the University of Bologna. 
 
3.4.1 Participants 
Patients were consecutively recruited in a primary care practice in Ravenna, located in 
Northern Italy. Subjects were provided with a detailed explanation of the study and 
subsequently invited to take part as volunteers in the research.  
Patients were excluded if < 18 or > 70 years old, had cognitive impairments, refused to 
cooperate, did not give written informed consent, presented with psychotic or significant pain 
symptoms.  
After signing the informed consent form patients were invited for a single clinical 
interview within the primary care practice, carried out by a trained clinical psychologist. 
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3.4.2 Assessment 
Participants underwent three detailed clinical interviews and completed three self-rating 
questionnaires for the assessment of psychopathology and psychosocial functioning: 
 
1. Structured Clinical Interview for DSM-5, SCID-5 (First et al., 2015)  
The SCID-5 is a semi-structured interview for obtaining DSM-5 diagnoses. The 
interview covers the following diagnoses: depressive and bipolar disorders; 
schizophrenia spectrum and other psychotic disorders; substance use disorders; anxiety 
disorders; obsessive-compulsive disorder; post-traumatic stress disorder; somatic 
symptom and related disorders; attention-deficit/hyperactivity disorder; and adjustment 
disorder.  
 
2. The Semi-Structured Interview for Diagnostic Criteria for Psychosomatic Research – 
Revised version (DCPR-R) (Fava et al., 2017)  
This interview was developed based on the previous interview for DCPR (Porcelli et al., 
2007), integrating the revised version of DCPR criteria, as outlined by Fava and 
colleagues (2017). Compared to the first version (Fava et al., 1995) the DCPR-R 
includes two additional syndromes (allostatic overload and hypochondriasis, which was 
retained from DSM-IV (APA, 2000)) and allows differentiation between helplessness 
and hopelessness in demoralization. Items of the interview for DCPR are scored 
through a yes/ no response format evaluating the presence of 14 psychosomatic 
syndromes: alexithymia, type A behavior, irritable mood, demoralization, disease 
phobia, thanatophobia, health anxiety, illness denial, functional somatic symptoms 
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secondary to a psychiatric disorder, persistent somatization, conversion symptoms, 
anniversary reaction, allostatic overload and hypochondriasis. The interview for DCPR 
(Porcelli et al, 2007) had shown excellent inter-rater reliability, construct validity and 
predictive validity for psychosocial functioning and treatment outcome (Galeazzi et al., 
2004). Diagnoses were formulated independently from the DSM.  
 
3. Clinical Interview for Depression – CID (Paykel, 1985; Guidi et al., 2011) 
The CID is an observer-rated dimensional assessment tool for assessing a wide range of 
affective symptoms, consisting of an expanded version of the Hamilton Rating Scale for 
Depression (Hamilton, M. 1967). The CID covers 36 symptom areas rated on 7-point 
scales with specification of each anchor point based on severity, frequency and/or 
quality of symptom. The CID has been used extensively as an outcome measure in 
several controlled clinical trials and follow-up studies of pharmacotherapy and 
psychotherapy of affective disorders (Fava & Kellner, 1991; Fava et al., 1994). 
Furthermore, the CID has been shown to be a valid and reliable tool with good 
clinimetric characteristics as well as high sensitivity to change in the broad evaluation 
of affective symptomatology (Guidi et al., 2011).  
 
4. PsychoSocial Index – PSI (Sonino & Fava, 1998; Piolanti et al., 2016)  
The PSI is a 55 – item self- rating scale based on clinimetric principles tailored for busy 
clinical setting.  
The PSI covers the following clinical domains: 
(a) Socio-demographic and clinical data: this part includes largely routine information 
about medical and psychiatric history, the patient’s family, employment and habits. It 
may alert clinicians to some threats to health, such as alcohol or drug use.  
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(b) Stress: this section is an integration of both perceived and objective stress, life 
events and chronic stress. It consists of 17 questions with a total score ranging from 0 to 
17. These questions contain essential information for case identification of allostatic 
overload  
(c) Well-being: this section covers different areas of well-being, i.e., positive relations 
with others, environmental mastery and autonomy, with a score ranging from 0 to 6.  
(d) Psychological distress: this section consists of a checklist of symptoms addressing 
sleep disturbances, somatization, anxiety, depression and irritability. The total score 
may range from 0 to 45.  
(e) Abnormal illness behavior: it allows the assessment of hypochondriacal beliefs and 
bodily preoccupations. The total score may range from 0 to 9.  
(f) Quality of life (item 55): a simple direct question on quality of life is included. The 
score ranges from 0 to 4.  
The items of the PSI were derived from the Screening List for Psychosocial Problems -
SLP (Kellner, 1991), the Wheatley Stress Profile (Wheatly, 1990), Ryff’s Scale of 
Psychological Well-being (Ryff, 2014) and Kellner’s Illness Attitude Scales (Kellner, 
1987; Sirri et al., 2008), all validated instruments. Some questions involve specific 
responses, most require a yes/no answer, while others are rated on a Likert 0–3 scale 
(from ‘not at all’ to ‘a great deal’). The PSI has been employed in various clinical 
populations in different countries and showed high sensitivity, discriminating varying 
degrees of psychosocial impairment in different populations (Piolanti et al., 2016). In 
this study, items concerning illness behavior were scored with the IAS.  
 
5. 12-item Short Form Health Survey– SF-12 (Ware, Kosinsky & Keller, 1996)  
The SF-12 is a self-report questionnaire, derived from the SF-36 (Ware, 1993) and 
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designed to measure a person’s perceived quality of life. The SF-12 surveys eight 
domains of health with answers to each question being scored on a 5-point Likert scale: 
physical functioning, role limitations due to physical health problems, bodily pain, 
general health, vitality (energy/fatigue), social functioning, role limitations due to 
emotional problems and mental health (psychological distress and psychological well-
being). An algorithm is used to transform the eight raw scores into norm-based scores. 
The SF-12 provides two aggregate summary measures of psychosocial functioning: the 
Physical Component Summary (PCS) and the Mental Component Summary (MCS). 
The SF-12 has been extensively validated and proved to be useful in comparing patient 
groups known to differ or to change in terms of the presence and seriousness of physical 
and mental conditions, acute symptoms, age and aging, self-reported 1-year changes in 
health, and recovery from depression (Ware et al., 1996). 
 
 
6. Illness Attitude Scales – IAS (Kellner, 1987; Sirri et al., 2008)  
The IAS consist of nine self-report scales concerning: (1) Worry about Illness (WI; 
general worry about having a serious illness), (2) Concern about Pain (CP; concerns that 
physical pain experiences may be indicative of an underlying disease), (3) Health 
Habits (HH; avoidance of behaviors that may be harmful to one's health), (4) 
Hypochondriacal Beliefs (HB; belief in the existence of a disease which physicians 
have failed to diagnose), (5) Thanatophobia (TH; fear of death), (6) Disease Phobia 
(DP; worries about having specific diseases), (7) Bodily Preoccupations (BP; a 
sensitivity to bodily sensations which may be indicative of illness), (8) Treatment 
Experiences (TE; how frequently a person has sought medical treatments) and (9) 
Effects of Symptoms (ES; the extent to which bodily symptoms interfere with general 
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functioning).  
Each scale contains three items rated on a 5-point Likert scale ranging from “no” to 
“most of the time”. For each scale, the score may range from 0 to 12, with higher scores 
corresponding to more severe hypochondriacal symptoms. The IAS scores showed both 
high discriminant validity in differentiating hypochondriacal patients from normal 
controls, family practice patients and non-hypochondriacal psychiatric patients and 
sensitivity to changes after treatment of hypochondriasis (Sirri, L. 2014; Weck, 
Bleichhardt & Hiller, 2010) 
 
 
 
3.4.3 Data analysis 
 
Data were entered into SPSS for Windows 20.0 (SPSS Inc., Chicago, IL, USA). The 
quality of data collection was monitored regularly to assure accuracy and completeness of data.  
Descriptive statistics were used to analyses socio-demographic/medical variables and to 
generate frequencies of psychiatric/psychosomatic diagnoses. 
Subgroup comparisons between DCPR/DSM-5 and unaffected groups, with regards to 
psychological measures of distress, stress, quality of life and illness behaviors were evaluated 
with the univariate analyses of variance using the general linear model (GLM), after controlling 
for socio-demographic and medical variables. DSM-5 and DCPR systems were examined 
separately and sub-groups were selected according to the most frequent diagnostic clusters.  
The distinct role played by DCPR and SSD in predicting psychological variables, in 
adjunction to DSM-5 diagnoses (not including SSD), was evaluated with a series of 
hierarchical regressions, controlled for socio-demographic and medical variables.  
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The extent to which DCPR syndromes, SSD and DSM-5 diagnoses were distinctly 
associated with psychosocial variables was evaluated with effect sizes by using Partial Eta 
Squared value (ηp). This measure was provided by the univariate analyses of variance using the 
general linear model. A standardized effect size of 0.01 is considered as small, 0.06 as medium 
and 0.14 as large (Levine & Hullet, 2002). 
 
 
3.5 Results 
 
3.5.1 Patients’ characteristics  
 
533 patients were approached to take part in the study.  Of these, 256 (47.5%) declined to 
participate (main reason being lack of time), 8 (1.5%) were older than 70 years old and 3 
(0.5%) had a psychotic disorder. Sixty-six (13.3%) subjects who agreed to participate did not 
attend psychological interview. Totally, the non-participants sample included 339 subjects 
(62.9%): 192 (56.7%) were females and 147 (43.3%) were males. Because of refusal to 
participate, clinical problems or not meeting the inclusion criteria, 200 patients (37.2%) entered 
the study and underwent psychological interview. Figure 1 shows the study flow-chart. 
In the study sample, there were 132 females (66%) and 68 males (34%), the mean age 
was 46.5 years (SD = 14.5), 129 patients (64.5%) were employed and 95 (47.5%) were married 
(Table 2). Out of the total sample, 82 (41%) patients had an active medical disease, mostly 
cardiac (19%), endocrine (12.5%) or pain disorders (7.5%). Twenty-two (11%) patients were 
taking psychiatric medications at the time of assessment, 111 (55.5%) acknowledged drinking 
alcohol, 50 (25%) smoking cigarettes and 11 (5.5%) using recreational drugs. 
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Figure 1. Study flow-chart 
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Table 1: Patients characteristics 
 n (200) % 
Sex   
   Male 68 34 
   Female 132 66 
Employment status   
   Employed 129 64.5 
   Unemployed 18 9.0 
   Retired, housewife, student 53 26.5 
Marital Status   
   Single 78 39 
   Married 95 47.5 
   Divorced/widowed 25 12.5 
Active Medical Disease 82 41 
Medical diagnostic groups   
   Cardiology 38 19 
   Endocrinology 25 12.5 
   Pain 15 7.5 
   Pulmonary 6 3 
   Gastroenterorology 5 2.5 
   Others 9 4.5 
   Smoking 50 25 
   Alchool use 111 55.5 
   Substance use 11 5.5 
   Psychiatric medication 22 11 
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3.5.2 Prevalence of DCPR and DSM-5 diagnoses 
 
Overall, 93 (46.5%) patients received at least 1 psychiatric (DSM-5) or psychological 
(DCPR) diagnosis (Figure 2). Forty-one patients (20,5%) had a diagnosis of both DCPR and 
DSM-5, 47 (23,5%) had a diagnosis of DCPR without DSM and 5 (2,5%) a diagnosis of DSM 
without DCPR.  
In total there were 46 patients (23%) with at least one DSM-5 diagnosis. Twelve (4.8%) 
patients received more than 1 DSM diagnosis. The most frequent diagnostic clusters were 
somatic symptom and related disorders (10%), mood disorders (8%) and anxiety disorders 
(7.5%) (Figure 3).  
As to mood disorders, 14 (7%) patients had major depression, 1 (0.5%) persistent 
depressive disorder and 1 (0.5%) bipolar disorder, type II. As to anxiety disorders, 5 (2.5%) 
patients had panic disorder, 5 (2.5%) agoraphobia, 1 (0.5%) social anxiety, 2 (1%) specific 
phobia and 2 (1%) generalized anxiety disorders. Five (2.5%) patients received a diagnosis of 
somatic symptom disorder, 11 (5.5%) illness anxiety and 4 (2.5%) psychological factors 
affecting medical conditions. Finally, 2 (1%) patients were diagnosed with eating disorder, 3 
(1.5%) with adjustment disorder and 2 (1%) with substance use disorder.  
Using DCPR criteria, 88 patients (44%) suffered from at least 1 DCPR syndrome (Figure 
4). Of these, 51 (25.5%) presented with more than 1 DCPR diagnosis. Thirty-one patients 
(15.5%) had allostatic load, 26 (13%) demoralization, of which 9  (4.5%) with hopelessness, 27 
(13.5%) had alexithymia, 23 (11.5%) irritable mood, 17 (8.5%) health anxiety, 16 (8%) 
persistent somatization, 12 (6%) type A behavior, 11 (5.5%) secondary somatic symptoms, 7 
(3.5%) illness denial, 5 (2.5%) thanatophobia, 4 (2%) disease phobia, 1 (0.5%) patient had 
hypochondriasis, 3 (1.5%) conversion symptoms and 2 (1%) anniversary reaction. 
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Figure 2.  Prevalence of DSM-5 and DCPR diagnoses 
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Figure 3. DSM-5 clusters  
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Figure 4. DCPR clusters  
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3.5.3 Between-groups comparisons  
 
1. DSM-5 
 
• At least one DSM-5 diagnosis 
 
Table 2 displays the differences in PSI, SF-12, IAS and CID scales’ scores of patients 
with at least 1 DSM diagnosis compared to those who had none (this group included subjects 
with no diagnosis and patients with DCPR diagnoses). 
One can observe how patients meeting DSM criteria showed significantly higher scores 
at PSI distress [F(1,195)=47.29; P<.001] and PSI stress [F(1,195)=5.08; P<.05], and 
significantly lower scores at PSI well-being [F(1,195)=22.40; P<.001], PSI quality of life 
[F(1,195)=21.24; P<.001] and SF-12 mental health component of quality of life 
[F(1,195)=25.30; P<.001], compared to the control group. No differences were observed at the 
SF-12 measure of the physical component of quality of life.  
As to the IAS, patients with at least 1 DSM diagnosis reported significantly higher scores 
at worry about illness [F(1,195)=9.47; P<.01], concerns about pain [F(1,195)=19.63; P<.001], 
hypochondriacal beliefs [F(1,195)=8.51; P<.01], thanathophobia [F(1,195)=16.97; P<.001], 
disease phobia [F(1,195)=14.63; P<.001], bodily preoccupations [F(1,195)=12.76; P<.001] and 
effects of symptoms [F(1,195)=20.80; P<.01] scales. No differences were observed at the 
health habits and treatment experience scales. 
Concerning the CID, the DSM-5 group reported significantly higher score at anxiety 
[F(1,195)=72.06; P<.001], depression [F(1,195)=59.51; P<.001] and total score scales 
[F(1,195)=98.70; P<.001], compared to the unaffected group.
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Table 2: Sub-group comparison of patients with and without* DSM-5 diagnoses at PSI, SF-12, IAS and CID 
controlled for age, gender and active medical diseases 
 
 DSM (+)  N= 46 DSM (-) N= 154 F (1,195) p 
Estimated marginal means 
(SE) 
Estimated marginal means 
(SE) 
     
PSI distress 14.57 ± 6.98 7.31 ± 5.17 47.29 <.001 
PSI stress 4.26 ± 2.74 3.19 ± 2.37 5.08 <.05 
PSI well-being 3.67 ± 1.55 4.84 ± 1.31 22.40 <.001 
PSI quality of life 1.98 ± 0.93 2.64 ± 0.72 21.24 <.001 
SF-12 PCS 47.84 ± 10.23 48.89 ± 8.51 0.03 NS 
SF-12 MCS 38.32 ± 10.45 47.82 ± 10.02 25.30 <.001 
IAS Worry about illness  6.87 ± 3.33 5.25 ± 2.62 9.47 <.01 
IAS Concerns about pain 6.33 ± 2.90 4.42 ± 2.28 19.63 <.001 
IAS Health habits  7.11 ± 3.33 6.91 ± 2.83 0.03 NS 
IAS Hypochondriacal beliefs  2.04 ± 2.47 1.03 ± 1.88 8.51 <.01 
IAS Thanatophobia 5.61 ± 3.78 3.13 ± 3.12 16.97 <.001 
IAS Disease phobia  3.46 ± 3.20 1.76 ± 2.05 14.63 <.001 
IAS Bodily preoccupations  4.61 ± 2.83 3.01 ± 2.26 12.76 <.001 
IAS Treatment experience  5.48 ± 2.56 4.40 ± 2.38 3.43 NS 
IAS Effects of symptoms  3.93 ± 3.34 1.69 ± 2.27 20.80 <.001 
CID anxiety 8.65 ± 2.72 5.53 ± 1.74 72.06 <.001 
CID depression 17.37 ± 5.49 12.36 ± 2.56 59.51 <.001 
CID total 63.91 ± 11.59 47.83 ± 7.62 98.70 <.001 
*Includes patients with no diagnosis and those with only DCPR diagnoses 
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• Mood disorders 
 
Table 3 displays the differences of patients with mood disorders compared to unaffected 
ones. This latter group excludes patients with other types of DSM-5. 
Patients with mood disorders showed significantly higher levels of psychological distress 
[F(1,165)=33.45; P<.001] and stress [F(1,165)=7.71; P<.01] and significantly lower scores of 
well-being [F(1,195)=12.36; P<.01], quality of life [F(1,165)=24.57; P<.001] and mental health 
quality of life [F(1,165)=19.07; P<.001].  
Few significant differences were found at IAS scales. Patients with DSM-5 mood 
disorders reported significant higher scores at treatment experience [F(1,165)=6.92; P<.01] and 
effect of symptoms [F(1,165)=19.30; P<.001] scales. Furthermore, they showed significant 
higher scores at anxiety [F(1,165)=11.05; P<.01], depression [F(1,165)=104.25; P<.001] and 
total score [F(1,165)=84.52; P<.001] scales of the CID. 
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Table 3: Sub-group comparison of patients with and without* mood disorders diagnoses at PSI, SF-12, IAS and 
CID controlled for age, gender and active medical diseases 
 
 Mood disorder (+)  N= 16 Mood disorder (-) N= 154 F (1,165) p 
Estimated marginal means 
(SE) 
Estimated marginal means 
(SE) 
     
PSI distress 16.56 ± 7.50 7.31 ± 5.17 33.45 <.001 
PSI stress 5.00 ± 2.58 3.19 ± 2.37 7.71 <.01 
PSI well-being 3.44 ± 1.67 4.84 ± 1.31 12.36 <.01 
PSI quality of life 1.56 ± 1.20 2.64 ± 0.72 24.57 <.001 
SF-12 PCS 42.65 ± 12.07 48.89 ± 8.51 3.86 NS 
SF-12 MCS 35.83 ± 10.50 47.82 ± 10.02 19.07 <.001 
IAS Worry about illness  5.88 ± 3.20 5.25 ± 2.62 0.62 NS 
IAS Concerns about pain 5.00 ± 2.8 4.42 ± 2.28 0.99 NS 
IAS Health habits  6.25 ± 3.27 6.91 ± 2.83 2.23 NS 
IAS Hypochondriacal beliefs  1.81 ± 2.2 1.03 ± 1.88 1.32 NS 
IAS Thanatophobia 4.56 ± 4.08 3.13 ± 3.12 3.11 NS 
IAS Disease phobia  2.94 ± 2.59 1.76 ± 2.05 2.46 NS 
IAS Bodily preoccupations  3.44 ± 2.52 3.01 ± 2.26 0.26 NS 
IAS Treatment experience  6.56 ± 2.30 4.40 ± 2.38 6.92 <.01 
IAS Effects of symptoms  5.06 ± 3.35 1.69 ± 2.27 19.30 <.001 
CID anxiety 7.44 ± 2.47 5.53 ± 1.74 11.05 <.01 
CID depression 16.56 ± 5.70 12.36 ± 2.56 104.25 <.001 
CID total 5.00 ± 13.59 47.83 ± 7.62 84.52 <.001 
*Includes patients with no diagnosis and those with only DCPR diagnoses 
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• Anxiety disorders 
 
Table 4 displays the differences of patients with anxiety disorders compared to unaffected 
ones. The unaffected group includes subjects with no diagnosis or with only DCPR diagnosis.  
Patients diagnosed with anxiety disorders reported significantly higher scores at PSI 
distress [F(1,163)=11.88; P<.001] and significantly worse physical [F(1,163)=6.14; P<.05] and 
mental [F(1,163)=9.59; P<.01] quality of life, as assessed by the SF-12, compared to the 
unaffected group. No significant differences were reported at PSI stress, well-being and quality 
of life. 
At IAS, they reported significantly higher scores of thanathophobia [F(1,163)=4.46; 
P<.05].  
Concerning the CID, patients diagnosed with anxiety disorders reported significantly 
higher score at anxiety [F(1,163)=67.70; P<.001], depression [F(1,163)=4.07; P<.05] and total 
score scales [F(1,163)=27.09; P<.001]. 
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Table 4: Sub-group comparison of patients with and without* anxiety disorders diagnoses at PSI, SF-12, IAS and 
CID controlled for age, gender and active medical diseases 
 
 Anxiety disorder (+)  N= 15 Anxiety disorder (-) N= 154 F (1,163) p 
Estimated marginal means 
(SE) 
Estimated marginal means 
(SE) 
     
PSI distress 12.60 ± 4.03 7.31 ± 5.17 11.88 <.001 
PSI stress 3.60 ± 2.50 3.19 ± 2.37 0.27 NS 
PSI well-being 4.40 ± 1.35 4.84 ± 1.31 0.88 NS 
PSI quality of life 2.33 ± 0.61 2.64 ± 0.72 1.97 NS 
SF-12 PCS 54.33 ± 3.63 48.89 ± 8.51 6.14 <.05 
SF-12 MCS 38.53 ± 10.52 47.82 ± 10.02 9.59 <.01 
IAS Worry about illness  5.93 ± 2.54 5.25 ± 2.62 0.36 NS 
IAS Concerns about pain 5.47 ± 2.56 4.42 ± 2.28 1.90 NS 
IAS Health habits  6.47 ± 3.72 6.91 ± 2.83 0.88 NS 
IAS Hypochondriacal beliefs  1.80 ± 2.93 1.03 ± 1.88 2.00 NS 
IAS Thanatophobia 5.33 ± 4.03 3.13 ± 3.12 4.46 <.05 
IAS Disease phobia  2.53 ± 2.74 1.76 ± 2.05 1.49 NS 
IAS Bodily preoccupations  4.27 ± 1.94 3.01 ± 2.26 3.41 NS 
IAS Treatment experience  4.00 ± 1.69 4.40 ± 2.38 0.89 NS 
IAS Effects of symptoms  2.33 ± 2.25 1.69 ± 2.27 0.87 NS 
CID anxiety 9.73 ± 2.71 5.53 ± 1.74 67.70 <.001 
CID depression 14.07 ± 2.89 12.36 ± 2.56 4.07 <.05 
CID total 59.40 ± 7.10 47.83 ± 7.62 27.09 <.001 
*Includes patients with no diagnosis and those with only DCPR diagnoses 
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• Somatic symptom and related disorders 
 
Table 5 displays the differences of patients with somatic symptoms and related disorders 
compared to unaffected ones. This latter group excludes patients with other types of DSM-5 
diagnoses. 
Patients identified in the category of somatic symptoms and related disorders reported 
significantly higher levels of psychological distress [F(1,169)=32.43; P<.001] and significantly 
lower scores of well-being [F(1,169)=14.55; P<.001], PSI quality of life [F(1,169)=11.59; 
P<.01] and SF-12 mental health quality of life [F(1,169)=16.63; P<.001], compared to the 
control group.  
As to the IAS, they reported significantly higher scores at health habits [F(1,169)=18.72; 
P<.001], concerns about pain [F(1,169)=16.63; P<.001], hypochondriacal beliefs 
[F(1,169)=30.27; P<.01], bodily preoccupations [F(1,169)=26.50; P<.01], disease phobia 
[F(1,169)=9.99; P<.001], effects of symptoms[F(1,169)=17.53; P<.001] and treatment 
experience [F(1,169)=27.26; P<.001].  
As to the CID, the somatic symptoms and related disorders group reported significantly 
higher score at anxiety [F(1,169)=54.44; P<.001], depression [F(1,169)=47.23; P<.001] and 
total score scales [F(1,169)=78.17; P<.001]. 
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Table 5: Sub-group comparison of patients with and without* somatic symptom and related disorders (SSD) 
diagnoses at PSI, SF-12, IAS and CID controlled for age, gender and active medical diseases 
 
 SSD (+)  N= 20 SSD (-) N= 154 F (1,169) p 
Estimated marginal means 
(SE) 
Estimated marginal means 
(SE) 
     
PSI distress 15.35 ± 8.77 7.31 ± 5.17 32.43 <.001 
PSI stress 4.05 ± 3.31 3.19 ± 2.37 1.83 NS 
PSI well-being 3.55 ± 1.76 4.84 ± 1.31 14.55 <.001 
PSI quality of life 2.00 ± 1.02 2.64 ± 0.72 11.59 <.01 
IAS Worry about illness  47.05 ± 10.06 48.89 ± 8.51 0.42 NS 
IAS Concerns about pain 37.78 ± 11.85 47.82 ± 10.02 16.63 <.001 
IAS Health habits  8.20 ± 3.90 5.25 ± 2.62 18.72 <.001 
IAS Hypochondriacal beliefs  7.60 ± 3.15 4.42 ± 2.28 30.27 <.001 
IAS Thanatophobia 7.25 ± 3.09 6.91 ± 2.83 0.08 NS 
IAS Disease phobia  2.55 ± 2.78 1.03 ± 1.88 9.99 <.001 
IAS Bodily preoccupations  7.00 ± 3.69 3.13 ± 3.12 26.50 <.001 
IAS Treatment experience  4.75 ± 3.69 1.76 ± 2.05 27.26 <.001 
IAS Effects of symptoms  5.50 ± 3.34 3.01 ± 2.26 17.53 <.001 
CID anxiety 9.00 ± 2.92 5.53 ± 1.74 54.44 <.001 
CID depression 17.80 ± 6.29 12.36 ± 2.56 47.23 <.001 
CID total 66.45 ± 14.07 47.83 ± 7.62 78.17 <.001 
*Includes patients with no diagnosis and those with only DCPR diagnoses 
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2. DCPR 
 
• At least one DCPR diagnosis 
 
Table 6 displays the differences in PSI, SF-12, IAS and CID scales’ scores of patients 
with at least 1 DCPR diagnosis compared to those who had none (this group also include 
patients with only DSM diagnosis). 
It can be observed that patients meeting DCPR disorders criteria showed significantly 
higher scores at PSI distress [F(1,195)=67.91; P<.001] and PSI stress [F(1,195)=34.25; 
P<.001], and significantly lower scores at PSI well-being [F(1,195)=62.04; P<.001], PSI 
quality of life [F(1,195)=42.03; P<.001] and SF-12 mental health component of quality of life 
[F(1,195)=67.40; P<.001], compared to the unaffected group. No differences were observed at 
the SF-12 measure of the physical component of quality of life.  
As to the IAS, patients with at least 1 DCPR diagnosis reported significantly higher 
scores at worry about illness [F(1,195)=17.46; P<.001], concerns about pain [F(1,195)=17.80; 
P<.001], hypochondriacal beliefs [F(1,195)=8.91; P<.01], thanathophobia [F(1,195)=28.92; 
P<.001], disease phobia [F(1,195)=14.72; P<.001], bodily preoccupations [F(1,195)=16.59; 
P<.001], treatment experience [F(1,195)=7.79; P<.01] and effects of symptoms 
[F(1,195)=25.90; P<.001] scales. No differences were observed at the health habits scale. 
Concerning the CID, the DCPR group reported significantly higher score at anxiety 
[F(1,195)=85.01; P<.001], depression [F(1,195)=60.78; P<.001] and total score scales 
[F(1,195)=111.66; P<.001]. 
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Table 6: Sub-group comparison of patients with and without* DCPR diagnoses at PSI, SF-12, IAS and CID 
controlled for age, gender and active medical diseases 
 
 DCPR (+)  N= 88 DCPR (-) N= 112 F (1,195) p 
Estimated marginal means 
(SE) 
Estimated marginal means 
(SE) 
     
PSI distress 12.86 ± 6.58 5.92 ± 4.25 67.91 <.001 
PSI stress 4.56 ± 2.67 2.55 ± 1.94 34.25 <.001 
PSI well-being 3.75 ± 1.48 5.22 ± 1.05 62.04 <.001 
PSI quality of life 2.08 ± 0.82 2.80 ± 0.66 42.03 <.001 
SF-12 PCS 48.39 ± 9.59 48.86 ± 8.39 0.002 NS 
SF-12 MCS 39.15 ± 10.41 50.72 ± 8.18 67.40 <.001 
IAS Worry about illness  6.63 ± 2.99 4.84 ± 2.52 17.46 <.001 
IAS Concerns about pain 5.74 ± 2.76 4.41± 2.28 17.80 <.001 
IAS Health habits  7.07 ± 3.21 6.87 ± 2.73 0.008 NS 
IAS Hypochondriacal beliefs  1.75 ± 2.51 0.88 ± 1.55 8.91 <.01 
IAS Thanatophobia 5.18 ± 3.51 2.54 ± 2.90 28.92 <.001 
IAS Disease phobia  2.94 ± 2.78 1.53 ± 1.99 14.72 <.001 
IAS Bodily preoccupations  4.23 ± 2.79 2.71 ± 1.99 16.59 <.001 
IAS Treatment experience  5.32 ± 2.53 4.13 ± 2.28 7.79 <.01 
IAS Effects of symptoms  3.34 ± 3.14 1.31 ± 1.91 25.90 <.001 
CID anxiety 7.81 ± 2.55 5.02 ± 1.32 85.01 <.001 
CID depression 15.90 ± 4.25 11.63 ± 2.66 60.78 <.001 
CID total 59.41 ± 10.53 45.34 ± 6.52 111.66 <.001 
*Includes patients with no diagnosis and those with only DSM-5 diagnoses 
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• Allostatic overload 
 
In Table 8 are reported the difference of patients diagnosed with allostatic overload (AO) 
compared to unaffected ones at PSI, SF-12, IAS and CID. The unaffected group includes 
subjects with no diagnosis and patients with only DSM-5 disorders, excluding patients with 
other types of DCPR disorders. 
Compared to the unaffected group, patients with AO reported significantly higher scores 
of distress [F(1,138)=43.32; P<.001] and stress [F(1,138)=33.37; P<.001], and significantly 
lower scores of well-being [F(1,138)=31.50; P<.001] and quality of life, measured at PSI 
[F(1,138)=13.97; P<.001] and SF-12 [F(1,138)=53.84; P<.001].  
As to the IAS, the AO group reported significantly higher scores at thanathophobia 
[F(1,138)=4.97; P<.05], disease phobia [F(1,138)=4.73; P<.05], bodily preoccupations 
[F(1,138)=6.59; P<.05] and effects of symptoms [F(1,138)=7.66; P<.01] scales.  
Furthermore, they displayed significantly higher score at anxiety [F(1,38)=80.19; 
P<.001], depression [F(1,138)=51.66; P<.001] and total score scales [F(1,138)=111.27; 
P<.001]. 
Figure 5 and Figure 6 show the comorbidity of AO with DSM or other DCPR diagnoses. 
Approximately 60% of patients diagnosed with AO did not meet any DSM criteria. 
Furthermore, the majority of them (68%) had comorbidity with other DCPR syndromes. 
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Table 8: Sub-group comparison of patients with and without* allostatic load (AO) diagnoses at PSI, SF-12, IAS 
and CID controlled for age, gender and active medical diseases 
 
 AO (+)  N= 31 AO (-) N= 112 F (1,138) p 
Estimated marginal means 
(SE) 
Estimated marginal means 
(SE) 
     
PSI distress 13.03 ± 5.00 5.92 ± 4.25 43.32 <.001 
PSI stress 5.00 ± 2.14 2.55 ± 1.94 33.37 <.001 
PSI well-being 3.81 ± 1.32 5.22 ± 1.054 31.50 <.001 
PSI quality of life 2.26 ± 0.68 2.80 ± 0.66 13.97 <.001 
SF-12 PCS 51.66 ± 6.32 48.86 ± 8.39 2.82 NS 
SF-12 MCS 37.10 ± 9.04 50.72 ± 8.18 53.84 <.001 
IAS Worry about illness  6.00 ± 2.92 4.84 ± 2.52 2.62 NS 
IAS Concerns about pain 5.13 ± 2.93 4.417± 2.28 1.92 NS 
IAS Health habits  7.06 ± 3.02 6.87 ± 2.73 0.21 NS 
IAS Hypochondriacal beliefs  0.84 ± 1.77 0.88 ± 1.55 0.19 NS 
IAS Thanatophobia 4.39 ± 3.73 2.54 ± 2.90 4.97 <.05 
IAS Disease phobia  2.77 ± 2.78 1.53 ± 1.99 4.73 <.05 
IAS Bodily preoccupations  4.10 ± 2.79 2.71 ± 1.99 6.59 <.05 
IAS Treatment experience  4.90 ± 2.15 4.13 ± 2.28 0.59 NS 
IAS Effects of symptoms  2.71 ± 2.31 1.31 ± 1.91 7.66 <.01 
CID anxiety 8.23 ± 2.40 5.02 ± 1.3 80.19 <.001 
CID depression 16.03 ± 2.54 11.63 ± 2.66 51.66 <.001 
CID total 61.77 ± 8.25 45.34 ± 6.50 111.27 <.001 
*Includes patients with no diagnosis and those with only DSM-5 diagnoses 
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Figure 5. AO comorbidity with DSM diagnoses 
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Figure 6. AO comorbidity with other DCPR diagnoses 
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• Demoralization 
 
Table 7 displays the differences in PSI, SF-12, IAS and CID scales’ scores of patients 
diagnosed with demoralization compared to non-cases. This latter group excludes patients with 
other types of DCPR disorders. 
Patients meeting demoralization criteria reported significantly higher scores of distress 
[F(1,133)=47.87; P<.001] and stress [F(1,133)=59.28; P<.001], and significantly lower scores 
of well-being [F(1,133)=51.09; P<.001] and quality of life, measured at PSI [F(1,133)=48.11; 
P<.001] and SF-12 [F(1,133)=69.19; P<.001], compared to the other group.  
Furthermore, they reported significantly higher scores at concerns about pain 
[F(1,133)=11.21; P<.01], hypochondriacal beliefs [F(1,133)=8.12; P<.01], thanathophobia 
[F(1,133)=13.50; P<.001], disease phobia [F(1,133)=6.39; P<.01], bodily preoccupations 
[F(1,133)=9.37; P<.01], treatment experience [F(1,133)=8.50; P<.001] and effects of symptoms 
[F(1,133)=26.51; P<.001] IAS scales.  
Concerning the CID, the demoralization group reported significantly higher score at 
anxiety [F(1,33)=44.62; P<.001], depression [F(1,133)=103.38; P<.001] and total score scales 
[F(1,133)=101.41; P<.001]. 
As shown in Figure 7, half of the patients diagnosed with demoralization were not 
identified by any DSM criteria. Of those identified, 35% had a diagnosis of mood disorders in 
comorbidity. The majority of diagnoses of demoralization (73%) had comorbidity with other 
DCPR diagnoses (Fig. 8), in particular with irritable mood (31%). 
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Table 7: Sub-group comparison of patients with and without* demoralization diagnoses at PSI, SF-12, IAS and 
CID controlled for age, gender and active medical diseases 
 
 Demoralization (+)  N= 26 Demoralization (-) N= 112 F (1,133) p 
Estimated marginal means 
(SE) 
Estimated marginal means 
(SE) 
     
PSI distress 14.42 ± 8.18 5.92 ± 4.25 47.87 <.001 
PSI stress 5.96 ± 2.66 2.55 ± 1.94 59.28 <.001 
PSI well-being 3.31 ± 1.56 5.22 ± 1.054 51.09 <.001 
PSI quality of life 1.65 ± 1.01 2.80 ± 0.66 48.11 <.001 
SF-12 PCS 47.27 ± 10.76 48.86 ± 8.39 0.26 NS 
SF-12 MCS 34.80 ± 9.87 50.72 ± 8.18 69.19 <.001 
IAS Worry about illness  5.88 ± 3.92 4.84 ± 2.52 2.60 NS 
IAS Concerns about pain 5.92 ± 3.05 4.417± 2.28 11.21 <.001 
IAS Health habits  5.92 ± 3.64 6.87 ± 2.73 3.79 NS 
IAS Hypochondriacal beliefs  2.15 ± 2.89 0.88 ± 1.55 8.12 <.01 
IAS Thanatophobia 5.19 ± 4.21 2.54 ± 2.90 13.50 <.001 
IAS Disease phobia  2.88 ± 2.71 1.53 ± 1.99 6.39 <.05 
IAS Bodily preoccupations  4.31 ± 3.23 2.71 ± 1.99 9.37 <.01 
IAS Treatment experience  6.00 ± 2.82 4.13 ± 2.28 8.50 <.01 
IAS Effects of symptoms  4.31 ± 3.86 1.31 ± 1.91 26.51 <.001 
CID anxiety 7.54 ± 2.43 5.02 ± 1.3 44.62 <.001 
CID depression 19.31 ± 5.03 11.63 ± 2.66 103.38 <.001 
CID total 64.12 ± 12.40 45.34 ± 6.50 101.41 <.001 
*Includes patients with no diagnosis and those with only DSM-5 diagnoses 
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Figure 7. Demoralization comorbidity with DSM diagnoses 
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Figure 8. Demoralization comorbidity with other DCPR diagnoses 
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• Illness behavior 
 
Table 9 displays the differences at PSI, SF-12, IAS and CID of patients with a diagnosis 
of illness behavior compared to those who had none. This latter group excludes patients with 
other types of DCPR. 
One can observe how patients diagnosed in the DCPR cluster of illness behavior showed 
significantly higher scores at PSI distress [F(1,147)=57.70; P<.001] and PSI stress 
[F(1,147)=21.14; P<.001], and significantly lower scores at PSI well-being [F(1,147)=55.14; 
P<.001], PSI quality of life [F(1,147)=31.10; P<.001] and SF-12 mental health component of 
quality of life [F(1,147)=42.96; P<.001]. No differences were observed at the SF-12 measure of 
the physical component of quality of life.  
As to the IAS, they reported significantly higher scores at worry about illness 
[F(1,147)=32.07; P<.001], concerns about pain [F(1,147)=33.65; P<.001], hypochondriacal 
beliefs [F(1,147)=15.77; P<.001], thanathophobia [F(1,147)=34.31; P<.001], disease phobia 
[F(1,147)=21.19; P<.001], bodily preoccupations [F(1,147)=23.85; P<.001], treatment 
experience  [F(1,147)=13.93; P<.001] and effects of symptoms [F(1,147)=35.39; P<.001] 
scales. No differences were observed at the health habits scale. 
Concerning the CID, the group of patients with anxiety disorders reported significantly 
higher score at anxiety [F(1,147)=112.01; P<.001], depression [F(1,147)=49.77; P<.001] and 
total score scales [F(1,195)=110.06; P<.001], in comparison to the unaffected group. 
As shown in Figure 9, more than 60% of patients with a DCPR diagnosis of illness 
behavior received a DSM diagnosis. The majority of them (43%) had a diagnosis of somatic 
symptom and related disorders in comorbidity.  
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Table 9: Sub-group comparison of patients with and without* illness behavior diagnoses at PSI, SF-12, IAS 
and CID controlled for age, gender and active medical diseases 
 
 Illness behavior (+)  N= 40 Illness behavior (-) N= 112 F (1,147) p 
Estimated marginal means 
(SE) 
Estimated marginal means 
(SE) 
     
PSI distress 14.15 ± 7.71 5.92 ± 4.25 57.70 <.001 
PSI stress 4.63 ± 2.91 2.55 ± 1.94 21.14 <.001 
PSI well-being 3.47 ± 1.51 5.22 ± 1.05 55.14 <.001 
PSI quality of life 1.97 ± 0.94 2.80 ± 0.66 31.10 <.001 
SF-12 PCS 46.36 ± 10.58 48.86 ± 8.39 1.56 NS 
SF-12 MCS 39.11 ± 11.10 50.72 ± 8.18 42.96 <.001 
IAS Worry about illness  7.70 ± 3.13 4.84 ± 2.52 32.07 <.001 
IAS Concerns about pain 6.70 ± 2.90 4.417± 2.28 33.65 <.001 
IAS Health habits  7.27 ± 3.12 6.87 ± 2.73 0.40 NS 
IAS Hypochondriacal beliefs  2.28 ± 2.65 0.88 ± 1.55 15.77 <.001 
IAS Thanatophobia 6.05 ± 3.42 2.54 ± 2.90 34.31 <.001 
IAS Disease phobia  3.75 ± 3.41 1.53 ± 1.99 21.19 <.001 
IAS Bodily preoccupations  4.98 ± 3.06 2.71 ± 1.99 23.85 <.010 
IAS Treatment experience  6.00 ± 2.50 4.13 ± 2.28 13.93 <.001 
IAS Effects of symptoms  4.23 ± 3.43 1.31 ± 1.91 35.39 <.001 
CID anxiety 8.48 ± 2.46 5.02 ± 1.32 112.01 <.001 
CID depression 16.55 ± 4.8 11.63 ± 2.66 49.77 <.001 
CID total 62.52 ± 11.8 45.34 ± 6.50 110.06 <.001 
*Includes patients with no diagnoses and those with only DSM-5 diagnoses 
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Figure 9. Illness behavior comorbidity with DSM diagnoses 
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Figure 10. Illness behavior comorbidity with other DCPR diagnoses 
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• Alexithymia 
 
Table 10 displays the differences in PSI, SF-12, IAS and CID scales’ scores of patients 
with alexithymia compared to those who had none. This latter group includes patients with no 
diagnosis and patients with DSM-5 disorders. 
Patients with alexithymia scored significantly higher at PSI distress [F(1,134)=39.78; 
P<.001] and PSI stress [F(1,134)=10.94; P<.01], and significantly lower at PSI well-being 
[F(1,134)=27.49; P<.001], PSI quality of life [F(1,134)=24.57; P<.001] and SF-12 mental 
health component of quality of life [F(1,134)=29.40; P<.001], compared to the non-cases 
group. No differences were observed at the SF-12 measure of the physical component of 
quality of life.  
Furthermore, these patients reported significantly higher scores at IAS worry about 
illness [F(1,134)=16.71; P<.001], concerns about pain [F(1,134)=11.86; P<.01], 
hypochondriacal beliefs [F(1,134)=9.91; P<.01], thanathophobia [F(1,134)=16.16; P<.001], 
disease phobia [F(1,134)=14.22; P<.001], bodily preoccupations [F(1,134)=8.93; P<.01] and 
effects of symptoms [F(1,134)=13.89; P<.001] scales. No differences were observed at the 
health habits and treatment experience scales. 
As to the CID, the alexythimia group reported significantly higher score in the anxiety 
[F(1,134)=83.20; P<.001], depression [F(1,134)=23.85; P<.001] and total score scales 
[F(1,134)=63.74; P<.001]. 
Figure 11 and Figure 12 show the comorbidity of alexythimia with DSM or other DCPR 
diagnoses. More than half of the patients diagnosed with alexythimia (56%) met criteria for a 
DSM diagnosis. The majority of them (30%) had a diagnosis of somatic symptoms and related 
disorders in comorbidity. As to the comorbidity with DCPR, the vast majority of patients with 
alexythimia (89%) met the criteria for other DCPR syndromes. 
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Table 10: Sub-group comparison of patients with and without* alexithymia diagnoses at PSI, SF-12, IAS and 
CID controlled for age, gender and active medical diseases 
 
 Alexithymia (+)  N= 27 Alexithymia (-) N= 112 F (1,134) p 
Estimated marginal means 
(SE) 
Estimated marginal means 
(SE) 
     
PSI distress 12.74 ± 6.49 5.92 ± 4.25 39.78 <.001 
PSI stress 4.11 ± 2.96 2.55 ± 1.94 10.94 <.01 
PSI well-being 3.85 ± 1.58 5.22 ± 1.05 27.49 <.001 
PSI quality of life 2.04 ± 0.75 2.80 ± 0.66 24.57 <.001 
SF-12 PCS 48.53 ± 8.99 48.86 ± 8.39 0.001 NS 
SF-12 MCS 40.10 ± 11.60 50.72 ± 8.18 29.40 <.001 
IAS Worry about illness  7.11 ± 2.40 4.84 ± 2.52 16.71 <.001 
IAS Concerns about pain 5.85 ± 2.39 4.417± 2.28 11.86 <.01 
IAS Health habits  7.19 ± 3.30 6.87 ± 2.73 0.19 NS 
IAS Hypochondriacal beliefs  2.11 ± 2.53 0.88 ± 1.55 9.91 <.01 
IAS Thanatophobia 5.22 ± 3.16 2.54 ± 2.90 16.16 <.001 
IAS Disease phobia  3.41 ± 2.85  1.53 ± 1.99 14.22 <.001 
IAS Bodily preoccupations  4.22 ± 2.97 2.71 ± 1.99 8.93 <.01 
IAS Treatment experience  5.22 ± 2.88 4.13 ± 2.80 3.01 NS 
IAS Effects of symptoms  3.19 ± 3.05 1.31 ± 1.91 13.89 <.001 
CID anxiety 8.41 ± 2.70 5.02 ± 1.32 83.20 <.001 
CID depression 15.00 ± 4.01 11.63 ± 2.66 23.85 <.001 
CID total 58.85 ± 10.85 45.34 ± 6.50 63.74 <.001 
*Includes patients with no diagnoses and those with only DSM-5 diagnoses 
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Figure 11. Alexythimia comorbidity with DSM diagnoses 
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Figure 12. Alexythimia comorbidity with other DCPR diagnoses 
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3.5.3 Predicting psychosocial variables from DCPR and SSD in adjunction of 
DSM-5 diagnoses (not including SSD) 
 
In order to evaluate and compare the predictive contribution of DCPR and SSD in 
addition to DSM-5 diagnoses, a series of hierarchical regression models were used with PSI, 
SF-12 and IAS scales as dependent variables. For all models, forced-entry variables in the first 
block were age, gender, presence of a medical disease and presence of any DSM-5 diagnoses 
(not including SSD). The second block was constituted by the presence of DCPR and presence 
of SSD diagnoses. 
 
 
Test for Multi-collinearity 
The analysis revealed that a very low level of multi-collinearity was present. VIF scores 
were 1.211 for DSM-5, 1.323 for DCPR and 1.147 for SSD. 
 
• Psychosocial Index (PSI) 
 
Variables included in the first block explained a significant portion of the variance of the 
distress, stress, well-being and quality of life scales. Presence of any DSM-5 (not including 
SSD) in the first model was a significant predictor for all PSI measures expect of stress. 
Addition of DCPR and SSD variables in the second block significantly improved prediction of 
psychological distress [R2 change=0.17; F(2,193)=18.62; P <.001], stress [R2 change=0.13; 
F(2,193)=7.69; P<.001], well-being [R2 change=0.19; F(2,193)=11.59, P<.001]  and quality of 
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life [R2 change=0.11; F(2,193)=13.98; P<.001]. DSM-5, DCPR and SSD were all significant 
factors in the prediction of psychological distress. Effect size was large for DCPR (β=0.38; 
P<.001; ηp=0.15), medium for DSM-5 and (β=0.20; P<.001; ηp=0.05) small for SSD (β=0.14; 
P<.05; ηp=0.03). With regards to quality of life, only DSM-5 (β=0.19; P<.01; ηp=0.03) and 
DCPR (β=0.35; P<.001; ηp=0.11) were significant predictors. Furthermore, only DCPR 
showed a significant effect in the prediction of the well-being (β=0.45; P<.001) and stress 
scales (β=0.41; P<.001), with a large effect size. 
 
 
Table 11: Hierarchical regression analyses predicting PSI measures of psychological distress, stress, well-being 
and quality of life from psychosomatic syndromes (DCPR) and Somatic Symptoms and Related Disorders 
(SSD) in adjunction to psychiatric diagnoses (DSM-5 not including SSD), controlled for age, gender and active 
medical diseases 
 
 
PSI β 
 
p ηp 
 
R2 R2 
change 
d.f F F change p 
Psychological distress Model 1    0.19  (4,195) 11.45  <.001 
   Any DSM* 0.36 <.001 0.13       
Model 2    0.36 0.17 (2,193) 18.62 26.89 <.001 
   Any DSM* 0.20 <.001 0.05       
   Any DCPR 0.38 <.001 0.15       
   Any SSD 0.14 <.05 0.03       
Stress Model 1    0.06  (4,195) 3.26  <.05 
   Any DSM* 0.12 NS        
   Model 2    0.19 0.13 (2,193) 7.69 15.58 <.001 
   Any DSM* 0.00 NS        
   Any DCPR 0.41 <.001 0.13       
   Any SSD 0.06 NS        
Well-being Model 1    0.07  (4,195) 3.75  <.01 
   Any DSM* 0.23 <.01 0.05       
Model 2    0.26 0.19 (2,193) 11.59 25.38 <.001 
   Any DSM* 0.07 NS        
   Any DCPR 0.45 <.001 0.17       
   Any SSD 0.06 NS        
Quality of life Model 1    0.11  (4,195) 6.61  <.001 
   Any DSM* 0.31 <.001 0.09       
Model 2    0.20 0.11 (2,193) 13.98 9.64 <.001 
   Any DSM* 0.19 <.01 0.03       
   Any DCPR 0.35 <.001 0.11       
   Any SSD 0.03 NS        
*DSM-5 diagnoses not including SSD 
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• Short-Form health survey (SF-12) 
 
The Mental Component of quality of life (MCS) was significantly predicted by the 
variables included in the first block [R2=0.17; F(4,195)=10.047; P<.001]. In this model, the 
presence of any DSM-5 was a significant predictor (β=0.32; P<.001) with a large effect size 
(ηp=0.10). Addition of DCPR and SSD variables significantly improved prediction [R2 
change=0.16; F(2,193)=16.57, P<.001]. However only DCPR, not SSD, was found to 
significantly predict MCS (β=0.43; P<.001) showing a large effect size (ηp=0.17). In this 
model, DSM-5 remained significant (β=0.16; P<.01)], with a medium effect size (ηp=0.03). 
The Physical Component of quality of life (PCS) was not significantly predicted by any 
models. Neither DSM-5, DCPR nor SSD were significantly related to PCS. 
 
 
Table 12: Hierarchical regression analyses predicting Sf-12 Mental (MCS) and Physical Component (PCS) 
of quality of life from psychosomatic syndromes (DCPR) and Somatic Symptoms and Related Disorders 
(SSD) in adjunction to psychiatric diagnoses (DSM-5 not including SSD), controlled for age, gender and 
active medical diseases 
SF-12 β 
 
p ηp 
 
R2 R2 
change 
d.f F F change p 
MCS Model 1    0.17  (4,195) 10.04  <.001 
   Any DSM* 0.32 <.001 0.10       
Model 2    0.34 0.16 (2,193) 16.57 24.73 <.001 
   Any DSM* 0.16 <.01 0.03       
   Any DCPR 0.43 <.001 0.17       
   Any SSD 0.05 NS        
PCS Model 1    0.03  (4,195) 1.95  NS 
   Any DSM* 0.00 NS        
   Model 2    0.04 0.00 (2,193) 1.37 0.23 NS 
   Any DSM* 0.00 NS        
   Any DCPR 0.02 NS        
   Any SSD 0.05 NS        
*DSM-5 diagnoses not including SSD 
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• Illness Attitude Scale (IAS) 
 
Variables included in the first model significantly predicted the IAS measures of worry 
about illness, thanathophobia, bodily preoccupations, treatment experience and effect of 
symptoms. In this model, presence of any DSM-5 (excluding SSD) showed a significant effect 
only in the hypochondriacal beliefs and effect of symptoms scales. Addition of DCPR and SSD 
factors yielded a significant increase in the prediction of all scales except of health habits.  
Both DCPR and SSD were significant factors in the prediction of worry about illness 
[(β=0.23; P<.01; ηp=0.5) and (β=0.23; P<.01; ηp=0.05)], concerns about pain [(β=0.19; P<.05; 
ηp=0.03) and (β=0.28; P<.001; ηp=0.08)], thanathophobia [(β=0.28; P<.001; ηp=0.07) and 
(β=0.22; P<.01; ηp=0.05)], disease phobia [(β=0.17; P<.05; ηp=0.02) and (β=0.28; P<.001; 
ηp=0.07)] and bodily preoccupations [(β=0.21; P<.01; ηp=0.04) and (β=0.20; P<.01; 
ηp=0.04)]. However only DCPR was found to significantly predict the treatment experience 
(β=0.16; P<.05) and effect of symptoms scales (β=0.27; P<.001), with a small (ηp=0.02) and 
medium (ηp=0.06) effect size, respectively. 
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Table 13: Hierarchical regression analyses predicting Illness behaviors (IAS) from psychosomatic syndromes 
(DCPR) and Somatic Symptoms and Related Disorders (SSD) in adjunction to psychiatric diagnoses (DSM-5 
not including SSD), controlled for age, gender and active medical diseases 
 
IAS β 
 
p ηp 
 
R2 R2 change d.f F F change p 
Worry about illness Model 1    0.06  (4,195) 3.11  <.05 
   Any DSM* 0.03 NS        
Model 2    0.18 0.12 (2,193) 7.39 15.05 <.001 
   Any DSM* 0.09 NS        
   Any DCPR 0.23 <0.1 0.50       
   Any SSD 0.23 <0.1 0.05       
Concerns about pain Model 1    0.04  (4,195) 2.26  NS 
   Any DSM* 0.13 NS        
   Model 2    0.18 0.13 (2,193) 7.19 16.36 <.001 
   Any DSM* 0.01 NS        
   Any DCPR 0.19 <.05 0.03       
   Any SSD 0.28 <.001 0.08       
Health habits Model 1    0.03  (4,195) 1.60  NS 
   Any DSM* 0.09 NS        
Model 2    0.03 0.00 (2,193) 1.11 0.18 NS 
   Any DSM* 0.10 NS        
   Any DCPR 0.01 NS        
   Any SSD 0.03 NS        
Hypochondriacal beliefs Model 1    0.03  (4,195) 1.76  NS 
   Any DSM* 0.17 <.05 0.03       
Model 2    0.07 0.04 (2,193) 2.73 4.55 <.05 
   Any DSM* 0.10 NS        
   Any DCPR 0.13 NS        
   Any SSD 0.14 NS        
Thanathophobia Model 1    0.08  (4,195) 4.34  <.01 
   Any DSM* 0.13 NS        
   Model 2    0.22 0.14 (2,193) 9.52 18.35 <.001 
   Any DSM* 0.00 NS        
   Any DCPR 0.28 <.001 0.07       
   Any SSD 0.22 <.01 0.05       
Disease phobia Model 1    0.04  (4,195) 2.14  NS 
   Any DSM* 0.12 NS        
Model 2    0.16 0.12 (2,193) 6.43 14.41 <.001 
   Any DSM* 0.01 NS        
   Any DCPR 0.17 <.05 0.02       
   Any SSD 0.28 <.001 0.07       
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IAS β 
 
p ηp 
 
R2 R2 change d.f F F change p 
Bodily preoccupations Model 1    0.03  (4,195) 1.81  NS 
   Any DSM* 0.10 NS        
Model 2    0.13 0.10 (2,193) 5.20 11.58 <.001 
   Any DSM* 0.00 NS        
   Any DCPR 0.21 <.01 0.04       
   Any SSD 0.20 <.01 0.04       
Treatment experience Model 1    0.05  (4,195) 3.06  <.05 
   Any DSM* 0.09 NS        
   Model 2    0.09 0.03 (2,193) 3.22 3.39 <.05 
   Any DSM* 0.03 NS        
   Any DCPR 0.16 <.05 0.02       
   Any SSD 0.06 NS        
Effects of symptoms Model 1    0.11  (4,195) 6.36  <.001 
   Any DSM* 0.24 <.01 0.06       
Model 2    0.19 0.07 (2,193) 7.70 9.28 <.001 
   Any DSM* 0.13 NS        
   Any DCPR 0.27 <.001 0.06       
   Any SSD 0.07 NS        
*DSM-5 diagnoses not including SSD 
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3.6 Discussion 
 
This study evaluated the incremental information provided by specific psychological 
criteria (Diagnostic Criteria for Psychosomatic Research) in addition to standard psychiatric 
assessments (DSM-5) and compared to the category of somatic symptoms and related 
disorders, in a sample of 200 primary care patients. 
The results from this investigation showed that the prevalence of primary care patients 
with at least one psychiatric disorder as assessed by the DSM-5 was of 23%. This finding is in 
line with the results found in a large cross-cultural study conducted in 14 countries (Üstün & 
Sartorius, 1995) but higher than the prevalence found in previous studies in Italian primary care 
settings (Menchetti et al., 2007), which reported a prevalence of around 12%. The most 
frequent diagnostic clusters were somatic symptom and related disorders (10%), mood 
disorders (8%) and anxiety disorders (7.5%), consistent with previous epidemiological studies 
carried out in this setting (Üstün & Sartorius, 1995; Toft et al., 2005; Menchetti et al., 2007). 
As to psychosomatic disorders, the prevalence of patients with at least one DCPR diagnosis 
was of 44%. This is the first data concerning the occurrence of DCPR in the general population 
of primary care patients, showing a high prevalence of these sub-threshold conditions. 
Our findings showed that the DCPR allows the identification of psychopathology in the 
proportion of 4:1, as compared to the SSD category, when applied to patients in primary care. 
All cases identified through the SSD were detected also by the DCPR, whereas 34% of patients 
(N=68) could not be identified as presenting psychological distress without the use of the 
DCPR system. Similarly, the percentage of patients with at least 1 diagnosis rose from 23%, 
when using solely the DSM-5 (including in this case the SSD), to 46% when integrating the 
DCPR. The majority of these patients were diagnosed as presenting only DCPR (23.5%) or 
both DCPR and DSM (20%), whereas just the 2.5% was diagnosed as presenting with only 
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DSM-5. These findings lend support to the hypothesis that the DCPR are more suitable for 
classifying psychological distress in medical settings than the criteria for somatic symptom and 
related disorders, as it has been previously shown in a study conducted on patients with 
congestive heart failure (Guidi et al., 2013). Indeed Guidi and colleagues (2013) found that the 
DCPR identified psychological factors meaningful for the illness course in the proportion of 
3:1, as compared to the SSD in medical patients.  These results confirm that the use of the 
DSM-5 in primary care benefits from the integration of DCPR with regards to the sensitivity in 
identifying sub-threshold distress (Fava et al., 2007; Fava, Tomba & Sonino, 2012).  
As to DCPR, the most frequent psychosomatic syndromes were allostatic load, 
demoralization and alexythimia.  
Allostatic overload reflects the cumulative effects of stressful experiences in daily life, 
which is judged as exceeding the individual’s coping skills and might be associated to 
psychological symptoms. McEwen (2007) proposed a formulation of the relationship between 
stress and the processes leading to disease based on the concept of allostasis, the ability of the 
organism to achieve stability through change. It is a common clinical observation that stressful 
life events may be followed by health problems. Recently, the introduction of structured 
methods of data collection has allowed identification of the link between life events in the year 
preceding the onset of symptoms and a number of medical disorders (Fava, Cosci & Sonino, 
2017). Similarly, long-standing life situations and daily life stresses may be experienced by the 
individual as exceeding his/her coping capacities. Integrating an evaluation of allostatic load in 
the psychological assessment is important because the joint presence of allostatic load and a 
psychiatric disorder calls for a closer monitoring of the clinical situation for the risks factors 
associated to this condition.  Regardless of the presence of psychiatric, it has been shown that 
abnormalities in the biological markers associated with allostatic load increase health risk 
(Gruenewald et al., 2006; Ryff et al., 2006). 
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Demoralization results from the awareness of being unable to cope with a pressing 
problem and may have two different ways of expression: helplessness (the individual maintains 
the capacity to react but lacks adequate support) and hopelessness (when the individual feels 
he/she alone is responsible for the situation and there is nothing he/she or anyone else can do to 
overcome the problem) (Sweeney et al., 1970; Fava et al., 2017). In our sample, one patient 
with demoralization out of three presented with hopelessness. Hopelessness/giving up is likely 
to be linked to depressive illness and may provide a severity connotation to the diagnosis of 
major depressive disorder. The 35% of patients diagnosed with demoralization in this study had 
a comorbidity with mood disorders. However, demoralization and major depression may occur 
also independently, as major depression does not necessarily involve demoralization (Tecuta et 
al., 2015). According to a recent review (Porcelli and Guidi, 2015) demoralization have been 
found to be frequent the medically ill. 
Alexithymia characterizes patients who have difficulties in describing feelings and 
differentiating them from bodily sensations, a poor fantasy life, and an “operative” way of 
thinking (Sifneos, 1973). In medical patients, the DCPR category of alexithymia was found in 
about one third of the cases associated with a comorbid DSM-IV mood or anxiety disorder, in 
another third with various forms of somatization, and in the remaining sample with no 
psychiatric morbidity (Porcelli et al., 2013). Alexithymia seems linked to an increased risk and 
a worsened outcome of several medical conditions (Porcelli et al., 2003; Lumley et al., 2007; 
de Vries et al., 2012). 
Associations of DSM-5 and DCPR diagnoses (including allostatic load, demoralization, 
illness behavior and alexythimia sub-groups) with dimensional measures of psychological 
factors provided evidence that both classifications were able to identify cases with significantly 
higher levels of psychological distress, stress and maladaptive illness behaviors, as well as 
significantly impaired well-being and quality of life, compared to non-cases. 
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psychological symptoms of distress, significant associations were reported both at self-rated 
(PSI) and observer-rated (CID) scales, highlighting a convergence of the data obtained through 
different methodologies of assessment. Observer-rated methods make full use of the clinical 
experience and comparison potential of the interviewer, whereas self-rating methods allow a 
more direct assessment of the patient subjective perceptions (Fava, Tomba & Sonino, 2012). 
With regards to the specific diagnostic clusters, we found that mood and anxiety 
disorders were poorly related to measures of illness behaviors (IAS). A previous study found 
the IAS to correlate with measure of depression and anxiety in non-hypochondriacal 
populations (Sirri et al., 2008) but, in case of patients with hypochondriasis or functional 
somatic disorders, these associations were not reported (Kellner et al., 1988). It has been thus 
hypnotized that abnormal illness attitudes might be particularly influenced by the absence of 
clear explanations and effective treatments for impairing functional symptoms, rather than a 
consequence of concomitant emotional disturbances (Sirri et al., 2008). 
As to patients diagnosed with somatic symptoms and related disorders, they were found 
to display significantly higher levels of psychological distress and maladaptive illness 
behaviors, as well as significantly impaired well-being and mental quality of life, compared to 
non-cases. However, compared to the DCPR-based classification, the SSD was not 
significantly related to the PSI measure of stress (life events and daily hassles), suggesting the 
higher sensitivity of DCPR to detect exposure to environmental challenges exceeding subjects’ 
resilience resources (Fava et al., 2010; Guidi et al., 2013).  
In order to further investigate the different contribution of SSD and DCPR criteria, in 
addition to DSM-5, for the assessment of primary care patients, we performed a series of 
hierarchical regressions, controlled for the effects of socio-demographic and medical variables. 
The main finding was that psychosomatic syndromes as assessed by the DCPR yielded more 
significant associations with psychosocial factors and a higher effect size, than the SSD. 
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Addition of the model including SSD and DCPR to DSM-5 significantly increased prediction 
of all PSI scales, SF-12 Mental Component of quality life (not significant for the Physical 
Component) and IAS (except for hypochondriacal beliefs and health habits). However, the 
predictive contribution of the SSD criteria was significant only for the PSI psychological 
distress scales and specific measures of illness behaviors (IAS). On the contrary, the DCPR 
significantly and transversely contributed to the prediction of almost all the variables included 
in the psychological assessment. Presence of any DCPR together with any DSM-5 was the best 
model of fit for the prediction of psychological distress and quality of life, as assessed by the 
PSI and SF-12. Furthermore, the DCPR had a large effect size over and above the DSM-5. 
These findings are consistent with those observed by Porcelli and colleagues (2009), showing 
that DCPR syndromes were independent predictors of quality of life, after controlling for 
DSM-IV psychopathology, in consultation-liason psychiatry. The ability of DCPR syndromes 
to predicting psychosocial problems among medical patients is also consistent with previous 
studies showing a close association between DCPR and psychosocial functioning measured 
with a variety of instruments in endocrinology (Sonino et al., 2004), dermatology (Picardi et 
al., 2005) and the general population (Mangelli et al., 2006).  
As to stress and well-being, DCPR was the only factor that yielded a significant 
contribution to the prediction model. The capacity of DCPR criteria to sensitively capture 
differences in measures of stress and well-being has been highlighted in diverse medical 
settings such as heart transplantations, cardiology and gastro-intestinal disorders (Rafanelli et 
al., 2003; Grandi et al., 2011; Rafanelli et al., 2012; Guidi et al., 2013). This is particularly 
important for the emerging area of intervention that is concerned with strategies increasing 
psychological well-being in all phases of medical illness, from prevention (decreased well-
being has been associated with unhealthy behaviors) to rehabilitation (the process of 
rehabilitation requires the promotion of well-being and changes in lifestyle) (Fava, Cosci & 
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Sonino, 2017). Increasing well-being by Well-Being Therapy may contribute to improving 
health attitudes and behavior, either in combination with other therapeutic strategies or as a 
first-line approach (Fava, 2016). 
With regards to the assessment of maladaptive illness behaviors, DCPR and SSD, not 
DSM-5, showed the best model of fit for the IAS. However, compared to the SSD, only the 
DCPR significantly predicted higher levels of physical impairment (effect of symptoms) and a 
higher frequency of medical treatments, examinations and visits to the doctor (treatment 
experience). This results underlines how the DSM-5 seems to neglect important information 
concerning the psychological factors affecting medical conditions and abnormal illness 
behaviors, such as patterns of psychosocial factors, coping strategies, burden of illness, effects 
of comorbid conditions, responses to previous treatments, and other clinical distinctions which 
are likely to influence the course, therapeutic response and outcome of a given illness (Porcelli 
& Guidi, 2015). On the other hand, the DCPR syndromes may broaden the clinician’s 
perspective on patient problems by providing clinical information that does not find any space 
in the traditional psychiatric classification and therefore may be suggested as operative tools in 
psychosomatic-based outpatient services and clinics.  Indeed, a previous study (Ferrari et al., 
2008) showed that DCPR criteria were associated to sub-threshold psychiatric comorbidity 
predicting a pattern of frequent attendance in primary care. This evidence further provides 
ground to the hypothesis that DCPR may have a role in mediating seek of medical care (Fava et 
al., 2017).  
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Limitations 
 
The present study has some limitations that should caution against generalizing the results. 
First, we found a high rate of refusal to undergo psychological assessment and the sample 
composition might reflect specific characteristics of patients willing to participate in the study.  
Second, data might have been influenced by situational variables and the temporal stability 
of the associations could not be ascertained due to the cross-sectional design of this study.  
 
 
 
 
3.7 Conclusions 
 
In conclusion, this study has the merit to compare the category of somatic symptom and 
related disorders with an alternative classification (DCPR), with regard to prevalence rates and 
by examining their distinct contribution to the prediction of psychosocial measures collected by 
means of both interviewer-based and self-rating instruments, in addition to the DSM-5 in 
primary care.  
Results from this investigation indicate that, in the setting of primary care, the DCPR 
classification is superior to the SSD category in evaluating psychosocial factors in presenting 
patients. A psychological assessment that includes DCPR is feasible and could expand our 
understanding of patients’ mental health status. Our findings support the need of broadening the 
assessment based on psychiatric taxonomy in primary care by integrating these specific 
psychological criteria. Furthermore, the results corroborate the clinical utility of the DCPR 
classification to provide useful information regarding the evaluation of psychosocial factors in 
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the psychological assessment of primary care patients. 
 
 
3.8 Clinical implications 
 
The results from this investigation might have important implication for the emergent 
role of Psychologists in integrated primary care services. The DCPR can provide Primary Care 
Psychologists with a sensitive tool for a comprehensive clinical assessment that can be 
integrated in the customary psychiatric assessment, enhancing the clinical utility of the DSM-5.  
The provision of an appropriate classification for primary care settings has the potential to form 
the basis for appropriate referral and timely treatment of psychosocial distress in primary care, 
thus guiding the process of clinical reasoning and medical decisions.  
 
 
 
3.9 Implications for future research 
 
Current findings support the need to investigate further the role that DCPR may play in 
primary care patients, such as the longitudinal stability of the diagnoses over time and their 
associations to psychosocial variables. Moreover, an important direction of future studies 
should include targeting DCPR syndromes through psychological therapy, with the aim of 
improving the quality of life and global state of patients, while reducing the costs associated to 
health care utilization. 
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